Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Waun Ki Hong
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Activities & Behaviors
Anatomy
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
128
Lippman, Scott
84
Lotan, Reuben
84
Shin, Dong
82
Lee, Jack
78
Lee, Jin
65
Khuri, Fadlo
57
Spitz, Margaret
51
Mao, Li
46
Hittelman, Walter
44
Kurie, Jonathan
43
Ro, Jae
38
Glisson, Bonnie
37
Lee, Ho-Young
37
Papadimitrakopoulou, Vassiliki
36
Benner, Steven
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Waun Ki Hong (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Saintigny Pierre; El-Naggar Adel K; Papadimitrakopoulou Vali; Ren Hening; Fan You-Hong; Feng Lei; Lee J Jack; Kim Edward S; Hong Waun Ki; Lippman Scott M; Mao Li
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(19):6284-91.
-
2009: Kim Woo-Young; Jin Quanri; Oh Seung-Hyun; Kim Edward S; Yang Youn Joo; Lee Dong Hoon; Feng Lei; Behrens Carmen; Prudkin Ludmila; Miller York E; Lee J Jack; Lippman Scott M; Hong Waun Ki; Wistuba Ignacio I; Lee Ho-Young
Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development.
Cancer research 2009;69(18):7439-48.
-
2009: Kadara Humam; Lacroix Ludovic; Behrens Carmen; Solis Luisa; Gu Xuemin; Lee J Jack; Tahara Eiji; Lotan Dafna; Hong Waun Ki; Wistuba Ignacio I; Lotan Reuben
Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system.
Cancer prevention research (Philadelphia, Pa.) 2009;2(8):702-11.
-
2009: Sun Menghong; Behrens Carmen; Feng Lei; Ozburn Natalie; Tang Ximing; Yin Guosheng; Komaki Ritsuko; Varella-Garcia Marileila; Hong Waun Ki; Aldape Kenneth D; Wistuba Ignacio I
HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(15):4829-37.
-
2009: Wu Xifeng; Spitz Margaret R; Lee J Jack; Lippman Scott M; Ye Yuanqing; Yang Hushan; Khuri Fadlo R; Kim Edward; Gu Jian; Lotan Reuben; Hong Waun K
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants.
Cancer prevention research (Philadelphia, Pa.) 2009;2(7):617-24.
-
2009: Woo Jong K; Choi Dong Soon; Tran Hai T; Gilbert Brian E; Hong Waun Ki; Lee Ho-Young
Liposomal encapsulation of deguelin: evidence for enhanced antitumor activity in tobacco carcinogen-induced and oncogenic K-ras-induced lung tumorigenesis.
Cancer prevention research (Philadelphia, Pa.) 2009;2(4):361-9.
-
2009: Kim Edward S; Mauer Ann M; William William N; Tran Hai T; Liu Diane; Lee Jack J; Windt Paul; Hong Waun K; Vokes Everett E; Herbst Roy S
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.
Cancer 2009;115(8):1713-22.
-
2009: Zinner Ralph G; Barrett Brittany L; Popova Elmira; Damien Paul; Volgin Andrei Y; Gelovani Juri G; Lotan Reuben; Tran Hai T; Pisano Claudio; Mills Gordon B; Mao Li; Hong Waun K; Lippman Scott M; Miller John H
Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells.
Molecular cancer therapeutics 2009;8(3):521-32.
-
2009: William William N; Lee Joseph L; Shin Dong M; Hong Waun K; Liu Suyu; Lee J Jack; Lippman Scott M; Khuri Fadlo R; Kim Edward S
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
American journal of clinical oncology 2009;32(1):15-9.
-
2009: Kim Woo-Young; Oh Seung Hyun; Woo Jong-Kyu; Hong Waun Ki; Lee Ho-Young
Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha.
Cancer research 2009;69(4):1624-32.
-
2009: Papadimitrakopoulou Vassiliki A; Lee J Jack; William William N; Martin Jack W; Thomas Margaret; Kim Edward S; Khuri Fadlo R; Shin Dong M; Feng Lei; Hong Waun Ki; Lippman Scott M
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):599-604.
-
2009: Papadimitrakopoulou Vassiliki; Izzo Julie G; Liu Diane D; Myers Jeffrey; Ceron Tania L; Lewin Jan; William William N; Atwell Anthea; Lee J Jack; Gillenwater Ann; El-Naggar Adel; Wu Xifeng; Lippman Scott M; Hittelman Walter N; Hong Waun Ki
Cyclin D1 and cancer development in laryngeal premalignancy patients.
Cancer prevention research (Philadelphia, Pa.) 2009;2(1):14-21.
-
2009: Zinner Ralph G; Komaki Ritsuko; Cox James D; Glisson Bonnie S; Pisters Katherine M W; Herbst Roy S; Kies Merril; Liao Zhongxing; Hong Waun K; Fossella Frank V
Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2009;73(1):119-27.
-
2008: Kim Woo-Young; Chang Dong Jo; Hennessy Bryan; Kang Hae Jin; Yoo Jakyung; Han Seung-Ho; Kim Yoo-Shin; Park Hyun-Ju; Seo Seung-Yong; Mills Gordon; Kim Kyu-Won; Hong Waun Ki; Suh Young-Ger; Lee Ho-Young
A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.
Cancer prevention research (Philadelphia, Pa.) 2008;1(7):577-87.
-
2008: Wu Xifeng; Lu Charles; Ye Yuanqing; Chang Joe; Yang Hushan; Lin Jie; Gu Jian; Hong Waun Ki; Stewart David; Spitz Margaret R
Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.
Pharmacogenetics and genomics 2008;18(11):955-65.
-
2008: Sporn Michael B; Hong Waun Ki
Concomitant DFMO and sulindac chemoprevention of colorectal adenomas: a major clinical advance.
Nature clinical practice. Oncology 2008;5(11):628-9.
-
2008: Behrens Carmen; Lin Heather Y; Lee J Jack; Raso Maria Gabriela; Hong Waun Ki; Wistuba Ignacio I; Lotan Reuben
Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(19):6014-22.
-
2008: Etzel Carol J; Kachroo Sumesh; Liu Mei; D'Amelio Anthony; Dong Qiong; Cote Michele L; Wenzlaff Angela S; Hong Waun Ki; Greisinger Anthony J; Schwartz Ann G; Spitz Margaret R
Development and validation of a lung cancer risk prediction model for African-Americans.
Cancer prevention research (Philadelphia, Pa.) 2008;1(4):255-65.
-
2008: Spitz Margaret R; Etzel Carol J; Dong Qiong; Amos Christopher I; Wei Qingyi; Wu Xifeng; Hong Waun Ki
An expanded risk prediction model for lung cancer.
Cancer prevention research (Philadelphia, Pa.) 2008;1(4):250-4.
-
2008: Jin Quanri; Menter David G; Mao Li; Hong Waun Ki; Lee Ho-Young
Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure.
Carcinogenesis 2008;29(8):1614-22.
-
2008: Zhang Li; Lee J Jack; Tang Hongli; Fan You-Hong; Xiao Lianchun; Ren Hening; Kurie Jonathan; Morice Rodolfo C; Hong Waun Ki; Mao Li
Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers.
Cancer prevention research (Philadelphia, Pa.) 2008;1(2):112-8.
-
2008: Bhutani Manisha; Pathak Ashutosh Kumar; Fan You-Hong; Liu Diane D; Lee J Jack; Tang Hongli; Kurie Jonathan M; Morice Rodolfo C; Kim Edward S; Hong Waun Ki; Mao Li
Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs.
Cancer prevention research (Philadelphia, Pa.) 2008;1(1):39-44.
-
2008: Sporn Michael B; Hong Waun Ki
Clinical prevention of recurrence of colorectal adenomas by the combination of difluoromethylornithine and sulindac: an important milestone.
Cancer prevention research (Philadelphia, Pa.) 2008;1(1):9-11.
-
2008: Kawaguchi Hidetoshi; El-Naggar Adel K; Papadimitrakopoulou Vali; Ren Hening; Fan You-Hong; Feng Lei; Lee J Jack; Kim Edward; Hong Waun Ki; Lippman Scott M; Mao Li
Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):354-60.
-
2008: Oh Seung-Hyun; Woo Jong K; Jin Quanri; Kang Hye-Jin; Jeong Joo-Won; Kim Kyu-Won; Hong Waun Ki; Lee Ho-Young
Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
International journal of cancer. Journal international du cancer 2008;122(1):5-14.
-
2007: Jin Quanri; Feng Lei; Behrens Carmen; Bekele B Nebiyou; Wistuba Ignacio I; Hong Waun-Ki; Lee Ho-Young
Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
Cancer research 2007;67(24):11630-9.
-
2007: Hittelman Walter N; Liu Diane D; Kurie Jonathan M; Lotan Reuben; Lee Jin Soo; Khuri Fadlo; Ibarguen Heladio; Morice Rodolfo C; Walsh Garrett; Roth Jack A; Minna John; Ro Jae Y; Broxson Anita; Hong Waun Ki; Lee J Jack
Proliferative changes in the bronchial epithelium of former smokers treated with retinoids.
Journal of the National Cancer Institute 2007;99(21):1603-12.
-
2007: Kim Seung-Wook; Cheon Kyounga; Kim Chang-Hoon; Yoon Joo-Heon; Hawke David H; Kobayashi Ryuji; Prudkin Ludmila; Wistuba Ignacio I; Lotan Reuben; Hong Waun Ki; Koo Ja Seok
Proteomics-based identification of proteins secreted in apical surface fluid of squamous metaplastic human tracheobronchial epithelial cells cultured by three-dimensional organotypic air-liquid interface method.
Cancer research 2007;67(14):6565-73.
-
2007: Tsao Anne S; He Dandan; Saigal Babita; Liu Suyu; Lee J Jack; Bakkannagari Srinivasa; Ordonez Nelson G; Hong Waun Ki; Wistuba Ignacio; Johnson Faye M
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.
Molecular cancer therapeutics 2007;6(7):1962-72.
-
2007: Oh Seung Hyun; Woo Jong Kyu; Yazici Yasemin Dakak; Myers Jeffrey N; Kim Woo-Young; Jin Quanri; Hong Soon Sun; Park Hyun-Ju; Suh Young-Ger; Kim Kyu-Won; Hong Waun Ki; Lee Ho-Young
Structural basis for depletion of heat shock protein 90 client proteins by deguelin.
Journal of the National Cancer Institute 2007;99(12):949-61.
-
2007: Morgillo Floriana; Kim Woo-Young; Kim Edward S; Ciardiello Fortunato; Hong Waun Ki; Lee Ho-Young
Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(9):2795-803.
-
2007: Spitz Margaret R; Hong Waun Ki; Amos Christopher I; Wu Xifeng; Schabath Matthew B; Dong Qiong; Shete Sanjay; Etzel Carol J
A risk model for prediction of lung cancer.
Journal of the National Cancer Institute 2007;99(9):715-26.
-
2006: Shen Jie; Behrens Carmen; Wistuba Ignacio I; Feng Lei; Lee J Jack; Hong Waun Ki; Lotan Reuben
Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry.
Cancer research 2006;66(23):11194-206.
-
2006: Wu Xifeng; Gu Jian; Dong Qiong; Huang Maosheng; Do Kim-Anh; Hong Waun Ki; Spitz Margaret R
Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7194-201.
-
2006: Tang Ximing; Liu Diane; Shishodia Shishir; Ozburn Natalie; Behrens Carmen; Lee J Jack; Hong Waun Ki; Aggarwal Bharat B; Wistuba Ignacio I
Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
Cancer 2006;107(11):2637-46.
-
2006: Morgillo Floriana; Woo Jong Kyu; Kim Edward S; Hong Waun Ki; Lee Ho-Young
Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.
Cancer research 2006;66(20):10100-11.
-
2006: Schroeder Claudia P; Kadara Humam; Lotan Dafna; Woo Jong K; Lee Ho-Young; Hong Waun Ki; Lotan Reuben
Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells.
Cancer research 2006;66(19):9762-70.
-
2006: Zhang Zhengdong; Wang Li-E; Sturgis Erich M; El-Naggar Adel K; Hong Waun K; Amos Christopher I; Spitz Margaret R; Wei Qingyi
Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5596-602.
-
2006: Papadimitrakopoulou Vassiliki A; Brown Erika N; Liu Diane D; El-Naggar Adel K; Jack Lee J; Hong Waun Ki; Lee Ho-Young
The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis.
Cancer letters 2006;239(1):136-43.
-
2006: Kelloff Gary J; Lippman Scott M; Dannenberg Andrew J; Sigman Caroline C; Pearce Homer L; Reid Brian J; Szabo Eva; Jordan V Craig; Spitz Margaret R; Mills Gordon B; Papadimitrakopoulou Vali A; Lotan Reuben; Aggarwal Bharat B; Bresalier Robert S; Kim Jeri; Arun Banu; Lu Karen H; Thomas Melanie E; Rhodes Helen E; Brewer Molly A; Follen Michele; Shin Dong M; Parnes Howard L; Siegfried Jill M; Evans Alison A; Blot William J; Chow Wong-Ho; Blount Patricia L; Maley Carlo C; Wang Kenneth K; Lam Stephen; Lee J Jack; Dubinett Steven M; Engstrom Paul F; Meyskens Frank L; O'Shaughnessy Joyce; Hawk Ernest T; Levin Bernard; Nelson William G; Hong Waun Ki;
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3661-97.
-
2006: Minard Charles G; Spitz Margaret R; Wu Xifeng; Hong Waun Ki; Etzel Carol J
Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Cancer 2006;106(12):2636-44.
-
2006: Tsao Anne S; Liu Diane; Lee J Jack; Spitz Margaret; Hong Waun Ki
Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.
Cancer 2006;106(11):2428-36.
-
2006: Lippman Scott M; Lee J Jack; Martin Jack W; El-Naggar Adel K; Xu Xiaochun; Shin Dong M; Thomas Margaret; Mao Li; Fritsche Herbert A; Zhou Xian; Papadimitrakopoulou Vassiliki; Khuri Fadlo R; Tran Hai; Clayman Gary L; Hittelman Walter N; Hong Waun Ki; Lotan Reuben
Fenretinide activity in retinoid-resistant oral leukoplakia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3109-14.
-
2006: McDonald Donald; Vogelstein Bert; King Marie-Claire; Hong Waun Ki; Augustin Hellmut; Hanahan Douglas; Lippman Marc
Wanted: cancer boss.
Nature 2006;440(7087):978-9.
-
2006: Khuri Fadlo R; Lee J Jack; Lippman Scott M; Kim Edward S; Cooper Jay S; Benner Steven E; Winn Rodger; Pajak Thomas F; Williams Brendell; Shenouda George; Hodson Ian; Fu Karen; Shin Dong M; Vokes Everett E; Feng Lei; Goepfert Helmuth; Hong Waun Ki
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Journal of the National Cancer Institute 2006;98(7):441-50.
-
2006: Tsao Anne S; Tang Xi Ming; Sabloff Bradley; Xiao Lianchun; Shigematsu Hisayuki; Roth Jack; Spitz Margaret; Hong Waun Ki; Gazdar Adi; Wistuba Ignacio
Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(3):231-9.
-
2006: Oh Seung-Hyun; Kim Woo-Young; Kim Jai-Hyun; Younes Maher N; El-Naggar Adel K; Myers Jeffrey N; Kies Merril; Cohen Pinchas; Khuri Fadlo; Hong Waun K; Lee Ho-Young
Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):653-61.
-
2006: Lu Charles; Spitz Margaret R; Zhao Hua; Dong Qiong; Truong Mylene; Chang Joe Y; Blumenschein George R; Hong Waun K; Wu Xifeng
Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma.
Cancer 2006;106(2):441-7.
-
2005: Oh Yun; Mohiuddin Imran; Sun Yan; Putnam Joseph B; Hong Waun Ki; Arap Wadih; Pasqualini Renata
Phenotypic diversity of the lung vasculature in experimental models of metastases.
Chest 2005;128(6 Suppl):596S-600S.
-
2005: Martin Linda W; Correa Arlene M; Hofstetter Wayne; Hong Waun Ki; Komaki Ritsuko; Putnam Joe B; Rice David C; Smythe W Roy; Swisher Stephen G; Vaporciyan Ara A; Walsh Garrett L; Roth Jack A
The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
The Journal of thoracic and cardiovascular surgery 2005;130(6):1601-10.
-
2005: Zinner Ralph G; Fossella Frank V; Gladish Gregory W; Glisson Bonnie S; Blumenschein George R; Papadimitrakopoulou Vassiliki A; Pisters Katherine M W; Kim Edward S; Oh Yun W; Peeples Beverly O; Ye Zhishen; Curiel Rafael E; Obasaju Coleman K; Hong Waun K; Herbst Roy S
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.
Cancer 2005;104(11):2449-56.
-
2005: Lee Ho-Young; Oh Seung-Hyun; Woo Jong K; Kim Woo-Young; Van Pelt Carolyn S; Price Roger E; Cody Dianna; Tran Hai; Pezzuto John M; Moriarty Robert M; Hong Waun Ki
Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis.
Journal of the National Cancer Institute 2005;97(22):1695-9.
-
2005: Johnson Faye M; Garden Adam S; Palmer J Lynn; Shin Dong M; Morrison William; Papadimitrakopoulou Vassiliki; Khuri Fadlo; Clayman Gary; Goepfert Helmuth; Ang K Kian; Hong Waun K; Glisson Bonnie S
A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
International journal of radiation oncology, biology, physics 2005;63(3):717-24.
-
2005: Han Ji-Youn; Oh Seung Hyun; Morgillo Floriana; Myers Jeffrey N; Kim Edward; Hong Waun Ki; Lee Ho-Young
Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.
Journal of the National Cancer Institute 2005;97(17):1272-86.
-
2005: Tang Ximing; Shigematsu Hisayuki; Bekele B Nebiyou; Roth Jack A; Minna John D; Hong Waun Ki; Gazdar Adi F; Wistuba Ignacio I
EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.
Cancer research 2005;65(17):7568-72.
-
2005: Lee Ho-Young; Oh Seung-Hyun; Suh Young-Ah; Baek Jin Hyen; Papadimitrakopoulou Vali; Huang Suyun; Hong Waun Ki
Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):6065-74.
-
2005: Herbst Roy S; Arquette Matthew; Shin Dong M; Dicke Karel; Vokes Everett E; Azarnia Nozar; Hong Waun Ki; Kies Merrill S
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5578-87.
-
2005: Lee Ho-Young; Chang Yoon Soo; Han Ji-Youn; Liu Diane D; Lee J Jack; Lotan Reuben; Spitz Margaret R; Hong Waun Ki
Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4439-49.
-
2005: Lu Charles; Perez-Soler Roman; Piperdi Bilal; Walsh Garrett L; Swisher Stephen G; Smythe W Roy; Shin Hyung J; Ro Jae Y; Feng Lei; Truong Mylene; Yalamanchili Adiseshu; Lopez-Berestein Gabriel; Hong Waun K; Khokhar Abdul R; Shin Dong M
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3495-501.
-
2005: Neumann Ana S; Lyons Heather J; Shen Hongbing; Liu Zhensheng; Shi Qiuling; Sturgis Erich M; Shete Sanjay; Spitz Margaret R; El-Naggar Adel; Hong Waun Ki; Wei Qingyi
Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis.
International journal of cancer. Journal international du cancer 2005;115(1):131-6.
-
2005: Sun Shi-Yong; Schroeder Claudia P; Yue Ping; Lotan Dafna; Hong Waun K; Lotan Reuben
Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrations.
Cancer biology & therapy 2005;4(4):407-13.
-
2005: Seixas-Silva Jose A; Richards Thomas; Khuri Fadlo R; Wieand H Samuel; Kim Ed; Murphy Barbara; Francisco Marites; Hong Waun Ki; Shin Dong M
Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up.
Archives of otolaryngology--head & neck surgery 2005;131(4):304-7.
-
2005: Kim Edward S; Hong Waun Ki
An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention.
Journal of the National Cancer Institute 2005;97(7):468-70.
-
2005: Herbst Roy S; Johnson David H; Mininberg Eric; Carbone David P; Henderson Ted; Kim Edward S; Blumenschein George; Lee Jack J; Liu Diane D; Truong Mylene T; Hong Waun K; Tran Hai; Tsao Anne; Xie Dong; Ramies David A; Mass Robert; Seshagiri Somasekar; Eberhard David A; Kelley Sean K; Sandler Alan
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(11):2544-55.
-
2005: Han Ji-Youn; Liu Diane D; Lee J Jack; Kurie Jonathan; Lotan Reuben; Hong Waun K; Lee Ho-Young
9-cis-retinoic acid treatment increases serum concentrations of alpha-tocopherol in former smokers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2305-11.
-
2005: Massarelli Erminia; Brown Erika; Tran Ngoc K; Liu Diane D; Izzo Julie G; Lee J Jack; El-Naggar Adel K; Hong Waun K; Papadimitrakopoulou Vassiliki A
Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis.
Cancer 2005;103(5):952-9.
-
2005: Vlastos Anne-Thérèse; West Loyd A; Atkinson E Neely; Boiko Iouri; Malpica Anais; Hong Waun K; Follen Michele
Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):390-6.
-
2005: Lippman Scott M; Sudbø Jon; Hong Waun Ki
Oral cancer prevention and the evolution of molecular-targeted drug development.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(2):346-56.
-
2004: Tang Ximing; Wu Weiguo; Sun Shi-Yong; Wistuba Ignacio I; Hong Waun Ki; Mao Li
Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
Molecular cancer research : MCR 2004;2(12):685-91.
-
2004: Zhang Zhengdong; Shi Qiuling; Sturgis Erich M; Spitz Margaret R; Hong Waun Ki; Wei Qingyi
Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7903-10.
-
2004: Do Kim-Anh; Johnson Marcella M; Lee J Jack; Wu Xi Feng; Dong Qiong; Hong Waun K; Khuri Fadlo R; Spitz Margaret R
Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies.
Cancer 2004;101(12):2837-42.
-
2004: Lu Charles; Soria Jean-Charles; Tang Ximing; Xu Xiao-Chun; Wang Luo; Mao Li; Lotan Reuben; Kemp Bonnie; Bekele B Nebiyou; Feng Lei; Hong Waun K; Khuri Fadlo R
Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4575-83.
-
2004: Lee Ho-Young; Moon Hojin; Chun Kyung-Hee; Chang Yoon-Soo; Hassan Khaled; Ji Lin; Lotan Reuben; Khuri Fadlo R; Hong Waun Ki
Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
Journal of the National Cancer Institute 2004;96(20):1536-48.
-
2004: Wang Luo; Rodriguez Marivonne; Kim Edward S; Xu Yunling; Bekele Neby; El-Naggar Adel K; Hong Waun Ki; Mao Li; Oh Yun W
A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.
International journal of oncology 2004;25(4):993-9.
-
2004: Li Guojun; Sturgis Erich M; Wang Li-E; Chamberlain Robert M; Amos Christopher I; Spitz Margaret R; El-Naggar Adel K; Hong Waun K; Wei Qingyi
Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck.
Carcinogenesis 2004;25(10):1911-6.
-
2004: Wang Jie; Lee J Jack; Wang Luo; Liu Diane D; Lu Charles; Fan You-Hong; Hong Waun Ki; Mao Li
Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6119-25.
-
2004: Tai Shyh-Kuan; Lee Janet I; Ang K Kian; El-Naggar Adel K; Hassan Khaled A; Liu Diane; Lee J Jack; Ren Hening; Hong Waun K; Mao Li
Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5554-7.
-
2004: Ren Hening; Tang Ximing; Lee J Jack; Feng Lei; Everett Allen D; Hong Waun Ki; Khuri Fadlo R; Mao Li
Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(16):3230-7.
-
2004: Chang Yoon Soo; Wang Luo; Suh Young-Ah; Mao Li; Karpen Saul J; Khuri Fadlo R; Hong Waun Ki; Lee Ho-Young
Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer.
Oncogene 2004;23(39):6569-80.
-
2004: Mao Li; Hong Waun Ki
How does human papillomavirus contribute to head and neck cancer development?
Journal of the National Cancer Institute 2004;96(13):978-80.
-
2004: Li Guojun; Sturgis Erich M; Wang Li-E; Chamberlain Robert M; Spitz Margaret R; El-Naggar Adel K; Hong Waun K; Wei Qingyi
Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):3996-4002.
-
2004: Wu Xifeng; Zhao Hua; Do Kim-Anh; Johnson Marcella M; Dong Qiong; Hong Waun Ki; Spitz Margaret R
Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):3988-95.
-
2004: Zhang Zhengdong; Shi Qiuling; Wang Li-E; Sturgis Erich M; Spitz Margaret R; El-Naggar Adel K; Hong Waun K; Wei Qingyi
No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(6):1081-3.
-
2004: Kim Edward S; Putnam Joe B; Komaki Ritsuko; Walsh Garrett L; Ro Jae Y; Shin Hyung Ju; Truong Mylene; Moon Hojin; Swisher Steven G; Fossella Frank V; Khuri Fadlo R; Hong Waun K; Shin Dong M
Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
Lung cancer (Amsterdam, Netherlands) 2004;44(3):369-79.
-
2004: Tsao Anne S; Kim Edward S; Hong Waun Ki
Chemoprevention of cancer.
CA: a cancer journal for clinicians 2004;54(3):150-80.
-
2004: Ozvaran Mustafa K; Cao Xiaobo X; Miller Steven D; Monia Brett A; Hong Waun Ki; Smythe W Roy
Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma.
Molecular cancer therapeutics 2004;3(5):545-50.
-
2004: Khuri Fadlo R; Glisson Bonnie S; Kim Edward S; Statkevich Paul; Thall Peter F; Meyers Michael L; Herbst Roy S; Munden Reginald F; Tendler Craig; Zhu Yali; Bangert Sandra; Thompson Elizabeth; Lu Charles; Wang Xue-Mei; Shin Dong M; Kies Merrill S; Papadimitrakopoulou Vali; Fossella Frank V; Kirschmeier Paul; Bishop W Robert; Hong Waun Ki
Phase I study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):2968-76.
-
2004: Mao Li; Hong Waun K; Papadimitrakopoulou Vassiliki A
Focus on head and neck cancer.
Cancer cell 2004;5(4):311-6.
-
2004: Youssef Emile M; Lotan Dafna; Issa Jean-Pierre; Wakasa Kenichi; Fan You-Hong; Mao Li; Hassan Khaled; Feng Lei; Lee J Jack; Lippman Scott M; Hong Waun K; Lotan Reuben
Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(5):1733-42.
-
2004: Lee Ho-Young; Suh Young-Ah; Kosmeder Jerome W; Pezzuto John M; Hong Waun Ki; Kurie Jonathan M
Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):1074-9.
-
2004: Yang Zhibo; Bagheri-Yarmand Rozita; Wang Rui-An; Adam Liana; Papadimitrakopoulou Vali Vassiliki; Clayman Gary L; El-Naggar Adel; Lotan Reuben; Barnes Christopher J; Hong Waun Ki; Kumar Rakesh
The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):658-67.
-
2004: Onn Amir; Correa Arlene M; Gilcrease Michael; Isobe Takeshi; Massarelli Erminia; Bucana Corazon D; O'Reilly Michael S; Hong Waun K; Fidler Isaiah J; Putnam Joe B; Herbst Roy S
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):136-43.
-
2003: Rudin Charles M; Cohen Ezra E W; Papadimitrakopoulou Vassiliki A; Silverman Sol; Recant Wendy; El-Naggar Adel K; Stenson Kirsten; Lippman Scott M; Hong Waun Ki; Vokes Everett E
An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4546-52.
-
2003: Soria Jean-Charles; Kim Edward S; Fayette Jérôme; Lantuejoul Sylvie; Deutsch Eric; Hong Waun Ki
Chemoprevention of lung cancer.
The lancet oncology 2003;4(11):659-69.
-
2003: Papadimitrakopoulou Vassiliki A; Ginsberg Lawrence E; Garden Adam S; Kies Merrill S; Glisson Bonnie S; Diaz Eduardo M; Clayman Gary; Morrison William H; Liu Diane D; Blumenschein George; Lippman Scott M; Schommer Donald; Gillenwater Ann; Goepfert Helmuth; Hong Waun K
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma.
Cancer 2003;98(10):2214-23.
-
2003: Shen Hongbing; Wei Qingyi; Pillow Patricia C; Amos Christopher I; Hong Waun K; Spitz Margaret R
Dietary folate intake and lung cancer risk in former smokers: a case-control analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(10):980-6.
-
2003: Rice David; Kim Hyung-Woo; Sabichi Anita; Lippman Scott; Lee J Jack; Williams Brendell; Vaporciyan Ara; Smythe W Roy; Swisher Stephen; Walsh Garrett; Putnam Joe B; Hong Waun Ki; Roth Jack
The risk of second primary tumors after resection of stage I nonsmall cell lung cancer.
The Annals of thoracic surgery 2003;76(4):1001-7; discussion 1007-8.
-
2003: Chang Yoon Soo; Wu Weiguo; Walsh Garrett; Hong Waun Ki; Mao Li
Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3641-4.
-
2003: Chun Kyung-Hee; Lee Ho-Young; Hassan Khaled; Khuri Fadlo; Hong Waun Ki; Lotan Reuben
Implication of protein kinase B/Akt and Bcl-2/Bcl-XL suppression by the farnesyl transferase inhibitor SCH66336 in apoptosis induction in squamous carcinoma cells.
Cancer research 2003;63(16):4796-800.
-
2003: Wu Xifeng; Amos Christopher I; Zhu Yong; Zhao Hua; Grossman Barton H; Shay Jerry W; Luo Sherry; Hong Waun Ki; Spitz Margaret R
Telomere dysfunction: a potential cancer predisposition factor.
Journal of the National Cancer Institute 2003;95(16):1211-8.
-
2003: Higuchi Eisaku; Chandraratna Roshantha A S; Hong Waun K; Lotan Reuben
Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype.
Oncogene 2003;22(30):4627-35.
-
2003: Tsao Anne S; McDonnell Timothy; Lam Stephen; Putnam Joe B; Bekele Nebiyou; Hong Waun Ki; Kurie Jonathan M
Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(7):660-4.
-
2003: Chun Kyung-Hee; Benbrook Doris M; Berlin K Darrell; Hong Waun Ki; Lotan Reuben
The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway.
Cancer research 2003;63(13):3826-32.
-
2003: Barnes Christopher J; Bagheri-Yarmand Rozita; Mandal Mahitosh; Yang Zhibo; Clayman Gary L; Hong Waun Ki; Kumar Rakesh
Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).
Molecular cancer therapeutics 2003;2(4):345-51.
-
2003: Do Kim-Anh; Johnson Marcella M; Doherty Dorota A; Lee J Jack; Wu Xi Feng; Dong Qiong; Hong Waun K; Khuri Fadlo R; Fu Karen K; Spitz Margaret R
Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States).
Cancer causes & control : CCC 2003;14(2):131-8.
-
2003: Wu Xifeng; Zhao Hua; Wei Qingyi; Amos Christopher I; Zhang Kerang; Guo Zhaozheng; Qiao Yawei; Hong Waun K; Spitz Margaret R
XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity.
Carcinogenesis 2003;24(3):505-9.
-
2003: Milas Ivan; Komaki Ritsuko; Hachiya Tsutomu; Bubb Robbin S; Ro Jae Y; Langford Lauren; Sawaya Raymond; Putnam Joe B; Allen Pamela; Cox James D; McDonnell Timothy J; Brock William; Hong Waun Ki; Roth Jack A; Milas Luka
Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):1070-6.
-
2003: Chun Kyung-Hee; Kosmeder Jerome W; Sun Shihua; Pezzuto John M; Lotan Reuben; Hong Waun Ki; Lee Ho-Young
Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells.
Journal of the National Cancer Institute 2003;95(4):291-302.
-
2003: Kurie Jonathan M; Lotan Reuben; Lee J Jack; Lee Jin Soo; Morice Rodolfo C; Liu Diane D; Xu Xiao-Chun; Khuri Fadlo R; Ro Jae Y; Hittelman Walter N; Walsh Garrett L; Roth Jack A; Minna John D; Hong Waun Ki
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial.
Journal of the National Cancer Institute 2003;95(3):206-14.
-
2003: Izzo Julie G; Papadimitrakopoulou Vassiliki A; Liu Diane D; den Hollander Petra L C; Babenko Ilona M; Keck Jamie; El-Naggar Adel K; Shin Dong M; Lee J Jack; Hong Waun K; Hittelman Walter N
Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer.
Journal of the National Cancer Institute 2003;95(3):198-205.
-
2003: Hong Waun Ki
General keynote: the impact of cancer chemoprevention.
Gynecologic oncology 2003;88(1 Pt 2):S56-8.
-
2003: Swisher Stephen G; Roth Jack A; Komaki Ritsuko; Gu Jian; Lee J Jack; Hicks Marshall; Ro Jae Y; Hong Waun K; Merritt James A; Ahrar Kamaran; Atkinson N Edward; Correa Arlene M; Dolormente Marcelo; Dreiling Linda; El-Naggar Adel K; Fossella Frank; Francisco Rhodette; Glisson Bonnie; Grammer Susan; Herbst Roy; Huaringa Armando; Kemp Bonnie; Khuri Fadlo R; Kurie Jonathan M; Liao Zhongxio; McDonnell Timothy J; Morice Rudolfo; Morello Frank; Munden Reginald; Papadimitrakopoulou Vassiliki; Pisters Katherine M W; Putnam Joe B; Sarabia Arcenio J; Shelton Thomas; Stevens Craig; Shin Daniel M; Smythe William R; Vaporciyan Ara A; Walsh Garrett L; Yin Min
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):93-101.
-
2003: Soria Jean-Charles; Xu Xiaochun; Liu Diane D; Lee J Jack; Kurie Jonathan; Morice Rodolfo C; Khuri Fadlo; Mao Li; Hong Waun K; Lotan Reuben
Retinoic acid receptor beta and telomerase catalytic subunit expression in bronchial epithelium of heavy smokers.
Journal of the National Cancer Institute 2003;95(2):165-8.
-
2003: Mintz Paul J; Kim Jeri; Do Kim-Anh; Wang Xuemei; Zinner Ralph G; Cristofanilli Massimo; Arap Marco A; Hong Waun Ki; Troncoso Patricia; Logothetis Christopher J; Pasqualini Renata; Arap Wadih
Fingerprinting the circulating repertoire of antibodies from cancer patients.
Nature biotechnology 2003;21(1):57-63.
-
2002: Papadimitrakopoulou Vassiliki A; Liu Diane D; Mao Li; Shin Dong M; El-Naggar Adel; Ibarguen Heladio; Lee J Jack; Hong Waun K; Hittelman Walter N
Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(12):1605-10.
-
2002: Chang Yoon Soo; Kong Gu; Sun Shihua; Liu Diane; El-Naggar Adel K; Khuri Fadlo R; Hong Waun Ki; Lee Ho-Young;
Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3796-802.
-
2002: Chang Yoon Soo; Wang Luo; Liu Diane; Mao Li; Hong Waun Ki; Khuri Fadlo R; Lee Ho-Young
Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3669-75.
-
2002: El-Naggar Adel K; Kim Hyung W; Clayman Gary L; Coombes Madelene M; Le Bao; Lai Syeling; Zhan Feng; Luna Mario A; Hong Waun Ki; Lee J Jack
Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification.
Oncogene 2002;21(53):8206-19.
-
2002: Hassan Khaled A; Ang K Kian; El-Naggar Adel K; Story Michael D; Lee Janet I; Liu Diane; Hong Waun K; Mao Li
Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.
Cancer research 2002;62(22):6414-7.
-
2002: Herbst Roy S; Madden Timothy L; Tran Hai T; Blumenschein George R; Meyers Christina A; Seabrooke Lee F; Khuri Fadlo R; Puduvalli Vinay K; Allgood Victoria; Fritsche Herbert A; Hinton Leslie; Newman Robert A; Crane Elizabeth A; Fossella Frank V; Dordal Margaret; Goodin Thomas; Hong Waun Ki
Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4440-7.
-
2002: Herbst Roy S; Hong Waun Ki
IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer.
Seminars in oncology 2002;29(5 Suppl 14):18-30.
-
2002: Lippman Scott M; Hong Waun Ki
Cancer prevention science and practice.
Cancer research 2002;62(18):5119-25.
-
2002: Herbst Roy S; Maddox Anne-Marie; Rothenberg Mace L; Small Eric J; Rubin Eric H; Baselga Jose; Rojo Federico; Hong Waun Ki; Swaisland Helen; Averbuch Steven D; Ochs Judith; LoRusso Patricia Mucci
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(18):3815-25.
-
2002: Herbst Roy S; Hess Kenneth R; Tran Hai T; Tseng Jennifer E; Mullani Nizar A; Charnsangavej Chusilp; Madden Timothy; Davis Darren W; McConkey David J; O'Reilly Michael S; Ellis Lee M; Pluda James; Hong Waun K; Abbruzzese James L
Phase I study of recombinant human endostatin in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(18):3792-803.
-
2002: Shen Hongbing; Wang Luo; Spitz Margaret R; Hong Waun K; Mao Li; Wei Qingyi
A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.
Cancer research 2002;62(17):4992-5.
-
2002: Zhu Yong; Spitz Margaret R; Zheng Yun-Ling; Hong Waun K; Wu Xifeng
BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk.
Cancer 2002;95(3):563-8.
-
2002: Rizvi Naiyer A; Marshall John L; Ness Elizabeth; Hawkins Michael J; Kessler Craig; Jacobs Helena; Brenckman Wayne D; Lee Jin S; Petros William; Hong Waun K; Kurie Jonathan M
Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(16):3522-32.
-
2002: Bubb Robbin S; Komaki Ritsuko; Hachiya Tsutomu; Milas Ivan; Ro Jae Y; Langford Lauren; Sawaya Raymond; Putnam Joe B; Allen Pamela; Cox James D; McDonnell Timothy J; Brock William; Hong Waun K; Roth Jack A; Milas Luka
Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.
International journal of radiation oncology, biology, physics 2002;53(5):1216-24.
-
2002: Herbst Roy S; Khuri Fadlo R; Lu Charles; Liu Diane D; Fossella Frank V; Glisson Bonnie S; Pisters Katherine M W; Shin Dong M; Papadimitrakopoulou Vassiliki A; Kurie Jonathan M; Blumenschein George; Kies Merrill S; Zinner Ralph; Jung Maria S; Lu Robert; Lee J Jack; Munden Reginald F; Hong Waun Ki; Lee Jin Soo
The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
Cancer 2002;95(2):340-53.
-
2002: Shin Dong M; Glisson Bonnie S; Khuri Fadlo R; Lippman Scott M; Ginsberg Lawrence; Diaz Edward; Papadimitrakopoulou Vassiliki; Feng Lei; Francisco Marites; Garden Adam; Kies Merrill S; Myers Jeffrey; Clayman Gary; Hong Waun Ki
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Cancer 2002;95(2):322-30.
-
2002: Schabath Matthew B; Spitz Margaret R; Hong Waun K; Delclos George L; Reynolds Wanda F; Gunn Gary B; Whitehead Lawrence W; Wu Xifeng
A myeloperoxidase polymorphism associated with reduced risk of lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;37(1):35-40.
-
2002: Lee Ho-Young; Chun Kyung-Hee; Liu Bingrong; Wiehle Sandra A; Cristiano Richard J; Hong Waun Ki; Cohen Pinchas; Kurie Jonathan M
Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
Cancer research 2002;62(12):3530-7.
-
2002: Shen Hongbing; Spitz Margaret R; Qiao Yawei; Zheng Yuxin; Hong Waun K; Wei Qingyi
Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis.
Lung cancer (Amsterdam, Netherlands) 2002;36(3):243-7.
-
2002: Wu Xifeng; Lippman Scott M; Lee J Jack; Zhu Yong; Wei Q Victoria; Thomas Margaret; Hong Waun Ki; Spitz Margaret R
Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
Cancer research 2002;62(10):2813-8.
-
2002: Wu Xifeng; Zhao Hua; Amos Christopher I; Shete Sanjay; Makan Nimisha; Hong Waun K; Kadlubar Fred F; Spitz Margaret R
p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.
Journal of the National Cancer Institute 2002;94(9):681-90.
-
2002: Sun Shi-Yong; Yue Ping; Chen Xueyun; Hong Waun K; Lotan Reuben
The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells.
Cancer research 2002;62(8):2430-6.
-
2002: Hastürk Serap; Kemp Bonnie; Kalapurakal Shyla K; Kurie Jonathan M; Hong Waun K; Lee Jin S
Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
Cancer 2002;94(4):1023-31.
-
2002: O'Shaughnessy Joyce A; Kelloff Gary J; Gordon Gary B; Dannenberg Andrew J; Hong Waun Ki; Fabian Carol J; Sigman Caroline C; Bertagnolli Monica M; Stratton Steven P; Lam Stephen; Nelson William G; Meyskens Frank L; Alberts David S; Follen Michele; Rustgi Anil K; Papadimitrakopoulou Vali; Scardino Peter T; Gazdar Adi F; Wattenberg Lee W; Sporn Michael B; Sakr Wael A; Lippman Scott M; Von Hoff Daniel D
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):314-46.
-
2002: Lippman Scott M; Hong Waun Ki
Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):305-13.
-
2002: Kim Kevin B; Lotan Reuben; Yue Ping; Sporn Michael B; Suh Nanjoo; Gribble Gordon W; Honda Tadashi; Wu Gen Sheng; Hong Waun Ki; Sun Shi-Yong
Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells.
Molecular cancer therapeutics 2002;1(3):177-84.
-
2002: Komaki R; Lee J S; Kaplan B; Allen P; Kelly J F; Liao Z; Stevens C W; Fossella F V; Zinner R; Papadimitrakopoulou V; Khuri F; Glisson B; Pisters K; Kurie J; Herbst R; Milas L; Ro J; Thames H D; Hong W K; Cox J D
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.
Seminars in radiation oncology 2002;12(1 Suppl 1):46-9.
-
2002: Soria Jean-Charles; Rodriguez Marivonne; Liu Diane D; Lee J Jack; Hong Waun Ki; Mao Li
Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.
Cancer research 2002;62(2):351-5.
-
2002: Shin Dong M; Glisson Bonnie S; Khuri Fadlo R; Clifford John L; Clayman Gary; Benner Steven E; Forastiere Arlene A; Ginsberg Lawrence; Liu Diane; Lee J Jack; Myers Jeffrey; Goepfert Helmuth; Lotan Reuben; Hong Waun Ki; Lippman Scott M
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):364-70.
-
2002: Oh Y; Osato M S; Han X; Bennett G; Hong W K
Folk yoghurt kills Helicobacter pylori.
Journal of applied microbiology 2002;93(6):1083-8.
-
2002: Wu Weiguo; Tang Ximing; Hu Wei; Lotan Reuben; Hong Waun Ki; Mao Li
Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.
Clinical & experimental metastasis 2002;19(4):319-26.
-
2002: Kim Edward S; Hong Waun Ki; Khuri Fadlo Raja
Chemoprevention of aerodigestive tract cancers.
Annual review of medicine 2002;53():223-43.
-
2001: Lee J I; Soria J C; Hassan K A; El-Naggar A K; Tang X; Liu D D; Hong W K; Mao L
Loss of PTEN expression as a prognostic marker for tongue cancer.
Archives of otolaryngology--head & neck surgery 2001;127(12):1441-5.
-
2001: Kim E S; Lu C; Khuri F R; Tonda M; Glisson B S; Liu D; Jung M; Hong W K; Herbst R S
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34(3):427-32.
-
2001: Tseng J E; Glisson B S; Khuri F R; Shin D M; Myers J N; El-Naggar A K; Roach J S; Ginsberg L E; Thall P F; Wang X; Teddy S; Lawhorn K N; Zentgraf R E; Steinhaus G D; Pluda J M; Abbruzzese J L; Hong W K; Herbst R S
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck.
Cancer 2001;92(9):2364-73.
-
2001: Follen M; Atkinson E N; Schottenfeld D; Malpica A; West L; Lippman S; Zou C; Hittelman W N; Lotan R; Hong W K
A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(11):3356-65.
-
2001: Jang S J; Soria J C; Wang L; Hassan K A; Morice R C; Walsh G L; Hong W K; Mao L
Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
Cancer research 2001;61(21):7959-63.
-
2001: Papadimitrakopoulou V A; Izzo J; Mao L; Keck J; Hamilton D; Shin D M; El-Naggar A; den Hollander P; Liu D; Hittelman W N; Hong W K
Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3127-34.
-
2001: Soria J C; Moon C; Wang L; Hittelman W N; Jang S J; Sun S Y; Lee J J; Liu D; Kurie J M; Morice R C; Lee J S; Hong W K; Mao L
Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers.
Journal of the National Cancer Institute 2001;93(16):1257-63.
-
2001: Hassan K A; El-Naggar A K; Soria J C; Liu D; Hong W K; Mao L
Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2458-62.
-
2001: Khuri F R; Kim E S; Lee J J; Winn R J; Benner S E; Lippman S M; Fu K K; Cooper J S; Vokes E E; Chamberlain R M; Williams B; Pajak T F; Goepfert H; Hong W K
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(8):823-9.
-
2001: Li D; Firozi P F; Chang P; Wang L E; Xiong P; Sturgis E M; Eicher S A; Spitz M R; Hong W K; Wei Q
In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck.
International journal of cancer. Journal international du cancer 2001;93(3):436-40.
-
2001: Lee J J; Liu D; Lee J S; Kurie J M; Khuri F R; Ibarguen H; Morice R C; Walsh G; Ro J Y; Broxson A; Hong W K; Hittelman W N
Long-term impact of smoking on lung epithelial proliferation in current and former smokers.
Journal of the National Cancer Institute 2001;93(14):1081-8.
-
2001: Shin D M; Khuri F R; Murphy B; Garden A S; Clayman G; Francisco M; Liu D; Glisson B S; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang K K; Lippman S M; Goepfert H; Hong W K
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3010-7.
-
2001: Shin D M; Charuruks N; Lippman S M; Lee J J; Ro J Y; Hong W K; Hittelman W N
p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(6):603-9.
-
2001: Sun S Y; Yue P; Kelloff G J; Steele V E; Lippman S M; Hong W K; Lotan R
Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(6):595-601.
-
2001: Wu X; Gwyn K; Amos C I; Makan N; Hong W K; Spitz M R
The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans.
Carcinogenesis 2001;22(6):923-8.
-
2001: Khuri F R; Rigas J R; Figlin R A; Gralla R J; Shin D M; Munden R; Fox N; Huyghe M R; Kean Y; Reich S D; Hong W K
Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2626-37.
-
2001: Shin D M; Donato N J; Perez-Soler R; Shin H J; Wu J Y; Zhang P; Lawhorn K; Khuri F R; Glisson B S; Myers J; Clayman G; Pfister D; Falcey J; Waksal H; Mendelsohn J; Hong W K
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1204-13.
-
2001: Jang S J; Chiba I; Hirai A; Hong W K; Mao L
Multiple oral squamous epithelial lesions: are they genetically related?
Oncogene 2001;20(18):2235-42.
-
2001: Soria J C; Izzo J; Mao L; Hong W K; Papadimitrakopoulou V A
[Biomarkers of carcinogenesis of the upper and lower airway epithelium and the role of chemoprevention]
Bulletin du cancer 2001;88(4):351-61.
-
2001: Lippman S M; Hong W K
Molecular markers of the risk of oral cancer.
The New England journal of medicine 2001;344(17):1323-6.
-
2001: Shen H; Spitz M R; Wang L E; Hong W K; Wei Q
Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(4):397-401.
-
2001: Kim J; Shin D M; El-Naggar A; Lee J S; Corrales C; Lippman S M; Hong W K; Hittelman W N
Chromosome polysomy and histological characteristics in oral premalignant lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(4):319-25.
-
2001: Khuri F R; Lee J S; Lippman S M; Lee J J; Kalapurakal S; Yu R; Ro J Y; Morice R C; Hong W K; Hittelman W N
Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(4):311-8.
-
2001: Lippman S M; Lee J J; Karp D D; Vokes E E; Benner S E; Goodman G E; Khuri F R; Marks R; Winn R J; Fry W; Graziano S L; Gandara D R; Okawara G; Woodhouse C L; Williams B; Perez C; Kim H W; Lotan R; Roth J A; Hong W K
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
Journal of the National Cancer Institute 2001;93(8):605-18.
-
2001: Khuri F R; Wu H; Lee J J; Kemp B L; Lotan R; Lippman S M; Feng L; Hong W K; Xu X C
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):861-7.
-
2001: Shin D M; Khuri F R; Glisson B S; Ginsberg L; Papadimitrakopoulou V M; Clayman G; Lee J J; Ang K K; Lippman S M; Hong W K
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Cancer 2001;91(7):1316-23.
-
2001: Pisters K M; Newman R A; Coldman B; Shin D M; Khuri F R; Hong W K; Glisson B S; Lee J S
Phase I trial of oral green tea extract in adult patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1830-8.
-
2001: Li D; Firozi P F; Wang L E; Bosken C H; Spitz M R; Hong W K; Wei Q
Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Cancer research 2001;61(4):1445-50.
-
2001: Lee J I; Soria J C; Hassan K; Liu D; Tang X; El-Naggar A; Hong W K; Mao L
Loss of Fhit expression is a predictor of poor outcome in tongue cancer.
Cancer research 2001;61(3):837-41.
-
2001: Wan H; Hong W K; Lotan R
Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Cancer research 2001;61(2):556-64.
-
2001: Hsu T C; Zhao Y J; Wang R Y; Wu Y F; Spitz M R; Hong W K
Comparative efficacy as antioxidants between ascorbic acid and epigallocatechin gallate on cells of two human lymphoblastoid lines.
Cancer genetics and cytogenetics 2001;124(2):169-71.
-
2000: Sun S Y; Yue P; Hong W K; Lotan R
Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
Cancer research 2000;60(24):7149-55.
-
2000: Papadimitrakopoulou V A; Hong W K
Biomolecular markers as intermediate end points in chemoprevention trials of upper aerodigestive tract cancer.
International journal of cancer. Journal international du cancer 2000;88(6):852-5.
-
2000: Pfister D G; Ang K; Brockstein B; Colevas A D; Ellenhorn J; Goepfert H; Hicks W L; Hong W K; Kies M S; Lydiatt W; McCaffrey T; Mittal B B; Ridge J A; Schuller D E; Shah J P; Spencer S; Trotti A; Urba S; Weymuller E A; Wheeler R H; Wolf G T;
NCCN Practice Guidelines for Head and Neck Cancers.
Oncology (Williston Park, N.Y.) 2000;14(11A):163-94.
-
2000: Sun S Y; Yue P; Hong W K; Lotan R
Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Cancer research 2000;60(22):6537-43.
-
2000: Roh H J; Shin D M; Lee J S; Ro J Y; Tainsky M A; Hong W K; Hittelman W N
Visualization of the timing of gene amplification during multistep head and neck tumorigenesis.
Cancer research 2000;60(22):6496-502.
-
2000: Kim E S; Hong W K; Khuri F R
Prevention of lung cancer. The new millennium.
Chest surgery clinics of North America 2000;10(4):663-90, v.
-
2000: Hong W K; Spitz M R; Lippman S M
Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(21 Suppl):9S-18S.
-
2000: Wei Q; Cheng L; Amos C I; Wang L E; Guo Z; Hong W K; Spitz M R
Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.
Journal of the National Cancer Institute 2000;92(21):1764-72.
-
2000: Shalev M; Thompson T C; Frolov A; Lippman S M; Hong W K; Fritsche H; Kadmon D
Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):3845-9.
-
2000: Spitz M R; Duphorne C M; Detry M A; Pillow P C; Amos C I; Lei L; de Andrade M; Gu X; Hong W K; Wu X
Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(10):1017-20.
-
2000: Lee H Y; Suh Y A; Robinson M J; Clifford J L; Hong W K; Woodgett J R; Cobb M H; Mangelsdorf D J; Kurie J M
Stress pathway activation induces phosphorylation of retinoid X receptor.
The Journal of biological chemistry 2000;275(41):32193-9.
-
2000: Tang X; Khuri F R; Lee J J; Kemp B L; Liu D; Hong W K; Mao L
Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer.
Journal of the National Cancer Institute 2000;92(18):1511-6.
-
2000: Sueoka N; Lee H Y; Wiehle S; Cristiano R J; Fang B; Ji L; Roth J A; Hong W K; Cohen P; Kurie J M
Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells.
Oncogene 2000;19(38):4432-6.
-
2000: Sueoka N; Lee H Y; Walsh G L; Fang B; Ji L; Roth J A; LaPushin R; Hong W K; Cohen P; Kurie J M
Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance with all-trans-retinoic acid treatment.
American journal of respiratory cell and molecular biology 2000;23(3):297-303.
-
2000: Sun S Y; Yue P; Chandraratna R A; Tesfaigzi Y; Hong W K; Lotan R
Dual mechanisms of action of the retinoid CD437: nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells.
Molecular pharmacology 2000;58(3):508-14.
-
2000: Wang L; Lin S H; Wu W G; Kemp B L; Walsh G L; Hong W K; Mao L
C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):2988-93.
-
2000: Kurie J M; Lee J S; Khuri F R; Mao L; Morice R C; Lee J J; Walsh G L; Broxson A; Lippman S M; Ro J Y; Kemp B L; Liu D; Fritsche H A; Xu X; Lotan R; Hong W K
N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):2973-9.
-
2000: Khuri F R; Shin D M; Glisson B S; Lippman S M; Hong W K
Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions.
Seminars in oncology 2000;27(4 Suppl 8):25-33.
-
2000: Soria J C; Jang S J; Khuri F R; Hassan K; Liu D; Hong W K; Mao L
Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
Cancer research 2000;60(15):4000-4.
-
2000: Khuri F R; Nemunaitis J; Ganly I; Arseneau J; Tannock I F; Romel L; Gore M; Ironside J; MacDougall R H; Heise C; Randlev B; Gillenwater A M; Bruso P; Kaye S B; Hong W K; Kirn D H
a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.
Nature medicine 2000;6(8):879-85.
-
2000: Khuri F R; Lotan R; Kemp B L; Lippman S M; Wu H; Feng L; Lee J J; Cooksley C S; Parr B; Chang E; Walsh G L; Lee J S; Hong W K; Xu X C
Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(15):2798-804.
-
2000: Cheng L; Spitz M R; Hong W K; Wei Q
Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis.
Carcinogenesis 2000;21(8):1527-30.
-
2000: Tae K; El-Naggar A K; Yoo E; Feng L; Lee J J; Hong W K; Hittelman W N; Shin D M
Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2821-8.
-
2000: Sun S Y; Wan H; Yue P; Hong W K; Lotan R
Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition.
The Journal of biological chemistry 2000;275(22):17149-53.
-
2000: Lee J J; Hong W K; Hittelman W N; Mao L; Lotan R; Shin D M; Benner S E; Xu X C; Lee J S; Papadimitrakopoulou V M; Geyer C; Perez C; Martin J W; El-Naggar A K; Lippman S M
Predicting cancer development in oral leukoplakia: ten years of translational research.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1702-10.
-
2000: Wu X; Yu H; Amos C I; Hong W K; Spitz M R
Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk.
Journal of the National Cancer Institute 2000;92(9):737-43.
-
2000: Wu X; Yu H; Amos C I; Hong W K; Spitz M R
Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2000;10 Suppl A():S26-7.
-
2000: Yen N; Ioannides C G; Xu K; Swisher S G; Lawrence D D; Kemp B L; El-Naggar A K; Cristiano R J; Fang B; Glisson B S; Hong W K; Khuri F R; Kurie J M; Lee J J; Lee J S; Merritt J A; Mukhopadhyay T; Nesbitt J C; Nguyen D; Perez-Soler R; Pisters K M; Putnam J B; Schrump D S; Shin D M; Walsh G L; Roth J A
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53).
Cancer gene therapy 2000;7(4):530-6.
-
2000: Sun S Y; Yue P; Mao L; Dawson M I; Shroot B; Lamph W W; Heyman R A; Chandraratna R A; Shudo K; Hong W K; Lotan R
Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1563-73.
-
2000: Liu N S; Spitz M R; Kemp B L; Cooksley C; Fossella F V; Lee J S; Hong W K; Khuri F R
Adenocarcinoma of the lung in young patients: the M. D. Anderson experience.
Cancer 2000;88(8):1837-41.
-
2000: Herbst R S; Yano S; Kuniyasu H; Khuri F R; Bucana C D; Guo F; Liu D; Kemp B; Lee J J; Hong W K; Fidler I J
Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):790-7.
-
2000: Zhou X; Kemp B L; Khuri F R; Liu D; Lee J J; Wu W; Hong W K; Mao L
Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):559-65.
-
2000: Nemunaitis J; Swisher S G; Timmons T; Connors D; Mack M; Doerksen L; Weill D; Wait J; Lawrence D D; Kemp B L; Fossella F; Glisson B S; Hong W K; Khuri F R; Kurie J M; Lee J J; Lee J S; Nguyen D M; Nesbitt J C; Perez-Soler R; Pisters K M; Putnam J B; Richli W R; Shin D M; Walsh G L; Merritt J; Roth J
Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):609-22.
-
2000: Shin D M; Mao L; Papadimitrakopoulou V M; Clayman G; El-Naggar A; Shin H J; Lee J J; Lee J S; Gillenwater A; Myers J; Lippman S M; Hittelman W N; Hong W K
Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.
Journal of the National Cancer Institute 2000;92(1):69-73.
-
1999: el-Naggar A K; Lai S; Tucker S A; Clayman G L; Goepfert H; Hong W K; Huff V
Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma.
Oncogene 1999;18(50):7063-9.
-
1999: Suzuki S; Higuchi M; Proske R J; Oridate N; Hong W K; Lotan R
Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.
Oncogene 1999;18(46):6380-7.
-
1999: Tseng J E; Rodriguez M; Ro J; Liu D; Hong W K; Mao L
Gender differences in p53 mutational status in small cell lung cancer.
Cancer research 1999;59(22):5666-70.
-
1999: Hong W K
Cancer chemoprevention: present status, future expectations.
Hospital practice (1995) 1999;34(11):101-5; discussion 105-6; quiz 164.
-
1999: Hong W K
Chemoprevention of lung cancer.
Oncology (Williston Park, N.Y.) 1999;13(10 Suppl 5):135-41.
-
1999: Papadimitrakopoulou V A; Clayman G L; Shin D M; Myers J N; Gillenwater A M; Goepfert H; El-Naggar A K; Lewin J S; Lippman S M; Hong W K
Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.
Archives of otolaryngology--head & neck surgery 1999;125(10):1083-9.
-
1999: Tseng J E; Kemp B L; Khuri F R; Kurie J M; Lee J S; Zhou X; Liu D; Hong W K; Mao L
Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
Cancer research 1999;59(19):4798-803.
-
1999: Garden A S; Glisson B S; Ang K K; Morrison W H; Lippman S M; Byers R M; Geara F; Clayman G L; Shin D M; Callender D L; Khuri F R; Goepfert H; Hong W K; Peters L J
Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2390-5.
-
1999: Glisson B S; Kurie J M; Perez-Soler R; Fox N J; Murphy W K; Fossella F V; Lee J S; Ross M B; Nyberg D A; Pisters K M; Shin D M; Hong W K
Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2309-15.
-
1999: Sueoka N; Lee H Y; Walsh G L; Hong W K; Kurie J M
Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.
Cancer research 1999;59(15):3838-44.
-
1999: Xu X C; Lee J S; Lee J J; Morice R C; Liu X; Lippman S M; Hong W K; Lotan R
Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention.
Journal of the National Cancer Institute 1999;91(15):1317-21.
-
1999: Sun S Y; Yue P; Shroot B; Hong W K; Lotan R
Implication of c-Myc in apoptosis induced by the retinoid CD437 in human lung carcinoma cells.
Oncogene 1999;18(26):3894-901.
-
1999: Papadimitrakopoulou V A; Hong W K
Combined-modality therapy in paranasal sinus cancer.
The cancer journal from Scientific American 1999;5(4):208-10.
-
1999: Wan H; Oridate N; Lotan D; Hong W K; Lotan R
Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
Cancer research 1999;59(14):3518-26.
-
1999: Sun S Y; Yue P; Wu G S; El-Deiry W S; Shroot B; Hong W K; Lotan R
Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.
Cancer research 1999;59(12):2829-33.
-
1999: Charuruks N; Shin D M; Voravud N; Ro J Y; Hong W K; Hittelman W N
P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1999;82(5):466-76.
-
1999: Kurie J M; Hong W K
Retinoids as antitumor agents: a new age of biological therapy.
The cancer journal from Scientific American 1999;5(3):150-1.
-
1999: Sun S Y; Li W; Yue P; Lippman S M; Hong W K; Lotan R
Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.
Cancer research 1999;59(10):2493-8.
-
1999: Swisher S G; Roth J A; Nemunaitis J; Lawrence D D; Kemp B L; Carrasco C H; Connors D G; El-Naggar A K; Fossella F; Glisson B S; Hong W K; Khuri F R; Kurie J M; Lee J J; Lee J S; Mack M; Merritt J A; Nguyen D M; Nesbitt J C; Perez-Soler R; Pisters K M; Putnam J B; Richli W R; Savin M; Schrump D S; Shin D M; Shulkin A; Walsh G L; Wait J; Weill D; Waugh M K
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.
Journal of the National Cancer Institute 1999;91(9):763-71.
-
1999: Sun S Y; Yue P; Wu G S; El-Deiry W S; Shroot B; Hong W K; Lotan R
Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells.
Oncogene 1999;18(14):2357-65.
-
1999: Wu W; Kemp B L; Proctor M L; Gazdar A F; Minna J D; Hong W K; Mao L
Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
Cancer research 1999;59(8):1846-51.
-
1999: Lee J S; Komaki R; Morice R C; Ro J Y; Kalapurakal S K; Schea R; Murphy W K; Shin D M; Fox N T; Walsh G L; Hittelman W N; Hong W K
A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer.
Seminars in radiation oncology 1999;9(2 Suppl 1):121-9.
-
1999: Lee H Y; Sueoka N; Hong W K; Mangelsdorf D J; Claret F X; Kurie J M
All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity.
Molecular and cellular biology 1999;19(3):1973-80.
-
1999: Sun S Y; Kurie J M; Yue P; Dawson M I; Shroot B; Chandraratna R A; Hong W K; Lotan R
Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):431-7.
-
1999: Zou C P; Hong W K; Lotan R
Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells.
Differentiation; research in biological diversity 1999;64(2):123-32.
-
1999: Yu H; Spitz M R; Mistry J; Gu J; Hong W K; Wu X
Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.
Journal of the National Cancer Institute 1999;91(2):151-6.
-
1998: Izzo J G; Papadimitrakopoulou V A; Li X Q; Ibarguen H; Lee J S; Ro J Y; El-Naggar A; Hong W K; Hittelman W N
Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
Oncogene 1998;17(18):2313-22.
-
1998: Geyer C; Papadimitrakopoulou V; Hong W K
Chemoprevention in head and neck cancer: basic science and clinical application.
Seminars in radiation oncology 1998;8(4):292-301.
-
1998: Lee J S; Komaki R; Fossella F V; Glisson B S; Hong W K; Cox J D
A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report.
International journal of radiation oncology, biology, physics 1998;42(3):479-86.
-
1998: Kim S K; Ro J Y; Kemp B L; Lee J S; Kwon T J; Hong W K; Mao L
Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer.
Oncogene 1998;17(13):1749-53.
-
1998: Mao L; El-Naggar A K; Papadimitrakopoulou V; Shin D M; Shin H C; Fan Y; Zhou X; Clayman G; Lee J J; Lee J S; Hittelman W N; Lippman S M; Hong W K
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.
Journal of the National Cancer Institute 1998;90(20):1545-51.
-
1998: Wan H; Dawson M I; Hong W K; Lotan R
Overexpressed activated retinoid X receptors can mediate growth inhibitory effects of retinoids in human carcinoma cells.
The Journal of biological chemistry 1998;273(41):26915-22.
-
1998: Oh Y; Proctor M L; Fan Y H; Su L K; Hong W K; Fong K M; Sekido Y S; Gazdar A F; Minna J D; Mao L
TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
Oncogene 1998;17(9):1141-8.
-
1998: Wu X; Gu J; Hong W K; Lee J J; Amos C I; Jiang H; Winn R J; Fu K K; Cooper J; Spitz M R
Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract.
Journal of the National Cancer Institute 1998;90(18):1393-9.
-
1998: Wu X; Gu J; Amos C I; Jiang H; Hong W K; Spitz M R
A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls.
Cancer 1998;83(6):1118-27.
-
1998: Zou Y; Zong G; Ling Y H; Hao M M; Lozano G; Hong W K; Perez-Soler R
Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes.
Journal of the National Cancer Institute 1998;90(15):1130-7.
-
1998: Roth J A; Atkinson E N; Fossella F; Komaki R; Bernadette Ryan M; Putnam J B; Lee J S; Dhingra H; De Caro L; Chasen M; Hong W K
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1998;21(1):1-6.
-
1998: Wang L E; Sturgis E M; Eicher S A; Spitz M R; Hong W K; Wei Q
Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(7):1773-8.
-
1998: Shin D M; Walsh G L; Komaki R; Putnam J B; Nesbitt J; Ro J Y; Shin H J; Ki K H; Wimberly A; Pisters K M; Schrump D; Gregurich M A; Cox J D; Roth J A; Hong W K
A multidisciplinary approach to therapy for unresectable malignant thymoma.
Annals of internal medicine 1998;129(2):100-4.
-
1998: Kurie J M; Lee J S; Morice R C; Walsh G L; Khuri F R; Broxson A; Ro J Y; Franklin W A; Yu R; Hong W K
Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers.
Journal of the National Cancer Institute 1998;90(13):991-5.
-
1998: Roth J A; Swisher S G; Merritt J A; Lawrence D D; Kemp B L; Carrasco C H; El-Naggar A K; Fossella F V; Glisson B S; Hong W K; Khurl F R; Kurie J M; Nesbitt J C; Pisters K; Putnam J B; Schrump D S; Shin D M; Walsh G L
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
Seminars in oncology 1998;25(3 Suppl 8):33-7.
-
1998: Lee H Y; Chaudhary J; Walsh G L; Hong W K; Kurie J M
Suppression of c-Fos gene transcription with malignant transformation of human bronchial epithelial cells.
Oncogene 1998;16(23):3039-46.
-
1998: El-Naggar A K; Coombes M M; Batsakis J G; Hong W K; Goepfert H; Kagan J
Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma.
Oncogene 1998;16(23):2983-7.
-
1998: Cheng L; Eicher S A; Guo Z; Hong W K; Spitz M R; Wei Q
Reduced DNA repair capacity in head and neck cancer patients.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(6):465-8.
-
1998: Clayman G L; el-Naggar A K; Lippman S M; Henderson Y C; Frederick M; Merritt J A; Zumstein L A; Timmons T M; Liu T J; Ginsberg L; Roth J A; Hong W K; Bruso P; Goepfert H
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2221-32.
-
1998: Zou C P; Kurie J M; Lotan D; Zou C C; Hong W K; Lotan R
Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(5):1345-55.
-
1998: Hillman R E; Walsh M J; Wolf G T; Fisher S G; Hong W K
Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group.
The Annals of otology, rhinology & laryngology. Supplement 1998;172():1-27.
-
1998: Shin D M; Glisson B S; Khuri F R; Hong W K; Lippman S M
Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Seminars in oncology 1998;25(2 Suppl 4):40-4; discussion 45-8.
-
1998: Wei Q; Eicher S A; Guan Y; Cheng L; Xu J; Young L N; Saunders K C; Jiang H; Hong W K; Spitz M R; Strom S S
Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(4):309-14.
-
1998: Wu X; Zhao Y; Honn S E; Tomlinson G E; Minna J D; Hong W K; Spitz M R
Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
Cancer research 1998;58(8):1605-8.
-
1998: Shin D M; Glisson B S; Khuri F R; Ginsberg L; Papadimitrakopoulou V; Lee J J; Lawhorn K; Gillenwater A M; Ang K K; Clayman G L; Callender D L; Hong W K; Lippman S M
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1325-30.
-
1998: Lee H Y; Walsh G L; Dawson M I; Hong W K; Kurie J M
All-trans-retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways.
The Journal of biological chemistry 1998;273(12):7066-71.
-
1998: Spitz M R; Shi H; Yang F; Hudmon K S; Jiang H; Chamberlain R M; Amos C I; Wan Y; Cinciripini P; Hong W K; Wu X
Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients.
Journal of the National Cancer Institute 1998;90(5):358-63.
-
1998: Lee H Y; Dohi D F; Kim Y H; Walsh G L; Consoli U; Andreeff M; Dawson M I; Hong W K; Kurie J M
All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor- dependent signaling pathway.
The Journal of clinical investigation 1998;101(5):1012-9.
-
1998: Mitchell M F; Tortolero-Luna G; Lee J J; Hittelman W N; Lotan R; Wharton J T; Hong W K; Nishioka K
Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):303-10.
-
1998: Spitz M R; Lippman S M; Jiang H; Lee J J; Khuri F; Hsu T C; Trizna Z; Schantz S P; Benner S; Hong W K
Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract.
Journal of the National Cancer Institute 1998;90(3):243-5.
-
1998: Kim S K; Su L K; Oh Y; Kemp B L; Hong W K; Mao L
Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
Oncogene 1998;16(1):89-93.
-
1998: Glisson B; Lee J S; Palmer J; Fossella F; Shin D M; Murphy W K; Perez-Soler R; Hong W K
Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Cancer 1998;82(2):301-8.
-
1998: Lippman S M; Benner S E; Fritsche H A; Lee J S; Hong W K
The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levels.
Cancer detection and prevention 1998;22(1):51-6.
-
1997: el-Naggar A K; Hurr K; Luna M A; Goepfert H; Hong W K; Batsakis J G
Intratumoral genetic heterogeneity in primary head and neck squamous carcinoma using microsatellite markers.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1997;6(6):305-8.
-
1997: Shin D M; Glisson B S; Khuri F R; Ginsberg L; Lawhorn K; Hong W K; Lippman S M
Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Seminars in oncology 1997;24(6 Suppl 19):S19-33-S19-37.
-
1997: Glisson B S; Hong W K
Survival after treatment of small-cell lung cancer: an endless uphill battle.
Journal of the National Cancer Institute 1997;89(23):1745-7.
-
1997: Sun S Y; Yue P; Shroot B; Hong W K; Lotan R
Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437.
Journal of cellular physiology 1997;173(2):279-84.
-
1997: Sun S Y; Yue P; Dawson M I; Shroot B; Michel S; Lamph W W; Heyman R A; Teng M; Chandraratna R A; Shudo K; Hong W K; Lotan R
Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Cancer research 1997;57(21):4931-9.
-
1997: Hong W K; Sporn M B
Recent advances in chemoprevention of cancer.
Science (New York, N.Y.) 1997;278(5340):1073-7.
-
1997: Papadimitrakopoulou V A; Hong W K
Retinoids in head and neck chemoprevention.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1997;216(2):283-90.
-
1997: Wan H; Dawson M I; Hong W K; Lotan R
Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
Oncogene 1997;15(17):2109-18.
-
1997: Spitz M R; McPherson R S; Jiang H; Hsu T C; Trizna Z; Lee J J; Lippman S M; Khuri F R; Steffen-Batey L; Chamberlain R M; Schantz S P; Hong W K
Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(9):687-92.
-
1997: Fossella F V; Lee J S; Hong W K
Management strategies for recurrent non-small cell lung cancer.
Seminars in oncology 1997;24(4):455-62.
-
1997: Oridate N; Suzuki S; Higuchi M; Mitchell M F; Hong W K; Lotan R
Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.
Journal of the National Cancer Institute 1997;89(16):1191-8.
-
1997: Hudmon K S; Honn S E; Jiang H; Chamberlain R M; Xiang W; Ferry G; Gosbee W; Hong W K; Spitz M R
Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(8):565-71.
-
1997: Shin D M; Xu X C; Lippman S M; Lee J J; Lee J S; Batsakis J G; Ro J Y; Martin J W; Hittelman W N; Lotan R; Hong W K
Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(6):875-80.
-
1997: Khuri F R; Kurie J M; Hong W K
Chemoprevention of respiratory tract cancer.
Hematology/oncology clinics of North America 1997;11(3):387-408.
-
1997: Mao L; Lee J S; Kurie J M; Fan Y H; Lippman S M; Lee J J; Ro J Y; Broxson A; Yu R; Morice R C; Kemp B L; Khuri F R; Walsh G L; Hittelman W N; Hong W K
Clonal genetic alterations in the lungs of current and former smokers.
Journal of the National Cancer Institute 1997;89(12):857-62.
-
1997: Wu X; Shi H; Jiang H; Kemp B; Hong W K; Delclos G L; Spitz M R
Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer.
Carcinogenesis 1997;18(5):967-73.
-
1997: Han G R; Dohi D F; Lee H Y; Rajah R; Walsh G L; Hong W K; Cohen P; Kurie J M
All-trans-retinoic acid increases transforming growth factor-beta2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent signaling pathway.
The Journal of biological chemistry 1997;272(21):13711-6.
-
1997: Xu X C; Sozzi G; Lee J S; Lee J J; Pastorino U; Pilotti S; Kurie J M; Hong W K; Lotan R
Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.
Journal of the National Cancer Institute 1997;89(9):624-9.
-
1997: Papadimitrakopoulou V; Izzo J; Lippman S M; Lee J S; Fan Y H; Clayman G; Ro J Y; Hittelman W N; Lotan R; Hong W K; Mao L
Frequent inactivation of p16INK4a in oral premalignant lesions.
Oncogene 1997;14(15):1799-803.
-
1997: Geara F B; Glisson B S; Sanguineti G; Tucker S L; Garden A S; Ang K K; Lippman S M; Clayman G L; Goepfert H; Peters L J; Hong W K
Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
Cancer 1997;79(7):1279-86.
-
1997: Perez-Soler R; Shin D M; Siddik Z H; Murphy W K; Huber M; Lee S J; Khokhar A R; Hong W K
Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(3):373-9.
-
1997: Papadimitrakopoulou V A; Dimery I W; Lee J J; Perez C; Hong W K; Lippman S M
Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
The cancer journal from Scientific American 1997;3(2):92-9.
-
1997: Shin H J; Kalapurakal S K; Lee J J; Ro J Y; Hong W K; Lee J S
Comparison of p53 immunoreactivity in fresh-cut versus stored slides with and without microwave heating.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(3):224-30.
-
1997: Lee H Y; Dawson M I; Claret F X; Chen J D; Walsh G L; Hong W K; Kurie J M
Evidence of a retinoid signaling alteration involving the activator protein 1 complex in tumorigenic human bronchial epithelial cells and non-small cell lung cancer cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(3):283-91.
-
1997: Oridate N; Higuchi M; Suzuki S; Shroot B; Hong W K; Lotan R
Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6-[3-(1-adamantyl)hydroxyphenyl]-2-naphtalene carboxylic acid (CD437).
International journal of cancer. Journal international du cancer 1997;70(4):484-7.
-
1997: Papadimitrakopoulou V A; Hong W K; Lee J S; Martin J W; Lee J J; Batsakis J G; Lippman S M
Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up.
Journal of the National Cancer Institute 1997;89(3):257-8.
-
1997: Khuri F R; Lippman S M; Spitz M R; Lotan R; Hong W K
Molecular epidemiology and retinoid chemoprevention of head and neck cancer.
Journal of the National Cancer Institute 1997;89(3):199-211.
-
1997: Kim S K; Ro J Y; Kemp B L; Lee J S; Kwon T J; Fong K M; Sekido Y; Minna J D; Hong W K; Mao L
Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer.
Cancer research 1997;57(3):400-3.
-
1997: Dimery I W; Hong W K; Lee J J; Guillory-Perez C; Pham F; Fritsche H A; Lippman S M
Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(1):85-9.
-
1997: Fossella F V; Lippman S M; Shin D M; Tarassoff P; Calayag-Jung M; Perez-Soler R; Lee J S; Murphy W K; Glisson B; Rivera E; Hong W K
Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):310-6.
-
1997: Mitchell M F; Tortolero-Luna G; Lee J J; Hittelman W K; Lotan R; Wharton J T; Hong W K; Nishioka K
Polyamine measurements in the uterine cervix.
Journal of cellular biochemistry. Supplement 1997;28-29():125-32.
-
1996: Charuruks N; Shin D M; Voravud N; Ro J Y; Hong W K; Hittelman W N
Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1996;79 Suppl 1():S104-12.
-
1996: Charuruks N; Shin D M; Voravud N; Ro J Y; Hong W K; Hittelman W N
Genetic instability and the development of recurrence of primary tumor and second primary tumor during head and neck tumorigenesis.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1996;79 Suppl 1():S49-55.
-
1996: Papadimitrakopoulou V A; Hong W K
Biology of oral premalignant lesions: concepts and implications for chemoprevention.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1996;5 Suppl 2():87-93.
-
1996: Garden A S; Lippman S M; Morrison W H; Glisson B S; Ang K K; Geara F; Hong W K; Peters L J
Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography.
International journal of radiation oncology, biology, physics 1996;36(5):1005-12.
-
1996: Mao L; El-Naggar A K; Fan Y H; Lee J S; Lippman S M; Kayser S; Lotan R; Hong W K
Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Cancer research 1996;56(24):5600-4.
-
1996: Mao L; Fan Y H; Lotan R; Hong W K
Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
Cancer research 1996;56(22):5128-31.
-
1996: Kurie J M; Shin H J; Lee J S; Morice R C; Ro J Y; Lippman S M; Hittelman W N; Yu R; Lee J J; Hong W K
Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(10):1787-93.
-
1996: Perez-Soler R; Glisson B S; Lee J S; Fossella F V; Murphy W K; Shin D M; Hong W K
Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2785-90.
-
1996: Wei Q; Cheng L; Hong W K; Spitz M R
Reduced DNA repair capacity in lung cancer patients.
Cancer research 1996;56(18):4103-7.
-
1996: Roth J A; Nguyen D; Lawrence D D; Kemp B L; Carrasco C H; Ferson D Z; Hong W K; Komaki R; Lee J J; Nesbitt J C; Pisters K M; Putnam J B; Schea R; Shin D M; Walsh G L; Dolormente M M; Han C I; Martin F D; Yen N; Xu K; Stephens L C; McDonnell T J; Mukhopadhyay T; Cai D
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.
Nature medicine 1996;2(9):985-91.
-
1996: Wei Q; Gu J; Cheng L; Bondy M L; Jiang H; Hong W K; Spitz M R
Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
Cancer research 1996;56(17):3975-9.
-
1996: Lee H Y; Dawson M I; Walsh G L; Nesbitt J C; Eckert R L; Fuchs E; Hong W K; Lotan R; Kurie J M
Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1996;7(8):997-1004.
-
1996: Huber M H; Lippman S M; Benner S E; Shirinian M; Dimery I W; Dunnington J S; Hong W K
A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
American journal of clinical oncology 1996;19(4):379-82.
-
1996: Schottenfeld D; Follen Mitchell M; Hong W K
Screening and chemoprevention of gynecologic tumors.
Obstetrics and gynecology clinics of North America 1996;23(2):285-94.
-
1996: Kim S K; Fan Y; Papadimitrakopoulou V; Clayman G; Hittelman W N; Hong W K; Lotan R; Mao L
DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma.
Cancer research 1996;56(11):2519-21.
-
1996: Mao L; Lee J S; Fan Y H; Ro J Y; Batsakis J G; Lippman S; Hittelman W; Hong W K
Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment.
Nature medicine 1996;2(6):682-5.
-
1996: Moe K; Wolf G T; Fisher S G; Hong W K
Regional metastases in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.
Archives of otolaryngology--head & neck surgery 1996;122(6):644-8.
-
1996: Oridate N; Lotan D; Xu X C; Hong W K; Lotan R
Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):855-63.
-
1996: Glisson B S; Hong W K
Primary chemotherapy of advanced head and neck cancer: where do we go from here?
Journal of the National Cancer Institute 1996;88(9):567-8.
-
1996: Shin D M; Lee J S; Lippman S M; Lee J J; Tu Z N; Choi G; Heyne K; Shin H J; Ro J Y; Goepfert H; Hong W K; Hittelman W N
p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
Journal of the National Cancer Institute 1996;88(8):519-29.
-
1996: Papadimitrakopoulou V A; Shin D M; Hong W K
Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.
Cancer metastasis reviews 1996;15(1):53-76.
-
1996: Lee J J; Trizna Z; Hsu T C; Spitz M R; Hong W K
A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(3):191-7.
-
1996: Kurie J M; Lee J S; Griffin T; Lippman S M; Drum P; Thomas M P; Weber C; Bader M; Massimini G; Hong W K
Phase I trial of 9-cis retinoic acid in adults with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(2):287-93.
-
1996: Perez-Soler R; Fossella F V; Glisson B S; Lee J S; Murphy W K; Shin D M; Kemp B L; Lee J J; Kane J; Robinson R A; Lippman S M; Kurie J M; Huber M H; Raber M N; Hong W K
Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):503-13.
-
1996: Huber M H; Lee J S; Newman R A; Fossella F V; Wester M; Hong W K; Lippman S M
A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(1):59-63.
-
1996: Kelloff G J; Crowell J A; Hawk E T; Steele V E; Lubet R A; Boone C W; Covey J M; Doody L A; Omenn G S; Greenwald P; Hong W K; Parkinson D R; Bagheri D; Baxter G T; Blunden M; Doeltz M K; Eisenhauer K M; Johnson K; Knapp G G; Longfellow D G; Malone W F; Nayfield S G; Seifried H E; Swall L M; Sigman C C
Strategy and planning for chemopreventive drug development: clinical development plans II.
Journal of cellular biochemistry. Supplement 1996;26():54-71.
-
1996: Hittelman W N; Kim H J; Lee J S; Shin D M; Lippman S M; Kim J; Ro J Y; Hong W K
Detection of chromosome instability of tissue fields at risk: in situ hybridization.
Journal of cellular biochemistry. Supplement 1996;25():57-62.
-
1996: Mitchell M F; Tortolero-Luna G; Wright T; Sarkar A; Richards-Kortum R; Hong W K; Schottenfeld D
Cervical human papillomavirus infection and intraepithelial neoplasia: a review.
Journal of the National Cancer Institute. Monographs 1996;(21):17-25.
-
1995: Verschraegen C; Conrad C A; Hong W K
Subacute encephalopathic toxicity of cisplatin.
Lung cancer (Amsterdam, Netherlands) 1995;13(3):305-9.
-
1995: Shin D M; Fossella F V; Umsawasdi T; Murphy W K; Chasen M H; Walsh G; Komaki R; McMurtrey M J; Hong W K
Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Cancer 1995;76(11):2230-6.
-
1995: Xu X C; Lee J S; Lippman S M; Ro J Y; Hong W K; Lotan R
Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(8):871-6.
-
1995: Kim Y H; Dohi D F; Han G R; Zou C P; Oridate N; Walsh G L; Nesbitt J C; Xu X C; Hong W K; Lotan R
Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors.
Cancer research 1995;55(23):5603-10.
-
1995: Xu X C; Zile M H; Lippman S M; Lee J S; Lee J J; Hong W K; Lotan R
Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression.
Cancer research 1995;55(23):5507-11.
-
1995: Mitchell M F; Hittelman W K; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Wharton J T; Hong W K
Chemoprevention trials and surrogate end point biomarkers in the cervix.
Cancer 1995;76(10 Suppl):1956-77.
-
1995: Benner S E; Lippman S M; Huber M H; Hong W K
Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
Seminars in oncology 1995;22(5 Suppl 12):22-5.
-
1995: Lee J S; Yoon A; Kalapurakal S K; Ro J Y; Lee J J; Tu N; Hittelman W N; Hong W K
Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):1893-903.
-
1995: Wolf G T; Hong W K
Induction chemotherapy for organ preservation in advanced laryngeal cancer: is there a role?
Head & neck 1995;17(4):279-83.
-
1995: Hong Y S; Kim S Y; Bhattacharya A; Pratt D R; Hong W K; Tainsky M A
Structure and function of the HOX A1 human homeobox gene cDNA.
Gene 1995;159(2):209-14.
-
1995: Benner S E; Lippman S M; Hong W K
Chemoprevention of lung cancer.
Chest 1995;107(6 Suppl):316S-321S.
-
1995: Lee J S; Newman R A; Lippman S M; Fossella F V; Calayag M; Raber M N; Krakoff I H; Hong W K
Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1501-8.
-
1995: Lotan R; Xu X C; Lippman S M; Ro J Y; Lee J S; Lee J J; Hong W K
Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.
The New England journal of medicine 1995;332(21):1405-10.
-
1995: Lippman S M; Spitz M R; Huber M H; Hong W K
Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck.
Current opinion in oncology 1995;7(3):234-41.
-
1995: Fossella F V; Lee J S; Berille J; Hong W K
Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.
Seminars in oncology 1995;22(2 Suppl 4):22-9.
-
1995: Benner S E; Lippman S M; Hong W K
Current status of retinoid chemoprevention of lung cancer.
Oncology (Williston Park, N.Y.) 1995;9(3):205-10; discussion 210, 213-4, 216.
-
1995: Battey J F; Brown P H; Gritz E R; Hong W K; Johnson B E; Karp D D; Mulshine J L; Shaw G L; Shopland D R; Sunday M E
Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshop.
Lung cancer (Amsterdam, Netherlands) 1995;12(1-2):91-103.
-
1995: Komaki R; Shin D M; Glisson B S; Fossella F V; Murphy W K; Garden A S; Oswald M J; Hong W K; Roth J A; Peters L J
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
International journal of radiation oncology, biology, physics 1995;31(4):807-11.
-
1995: Clayman G L; Weber R S; Guillamondegui O; Byers R M; Wolf P F; Frankenthaler R A; Morrison W H; Garden A S; Hong W K; Goepfert H
Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers.
Archives of otolaryngology--head & neck surgery 1995;121(2):219-23.
-
1995: Hays G L; Lippman S M; Flaitz C M; Brown R S; Pang A; Devoll R; Hong W K
Co-carcinogenesis and field cancerization: oral lesions offer first signs.
Journal of the American Dental Association (1939) 1995;126(1):47-51.
-
1995: Lippman S M; Shin D M; Lee J J; Batsakis J G; Lotan R; Tainsky M A; Hittelman W N; Hong W K
p53 and retinoid chemoprevention of oral carcinogenesis.
Cancer research 1995;55(1):16-9.
-
1995: Huber M H; Lippman S M; Benner S E; Shirinian M; Dimery I W; Earley C L; Winn R J; Brooks J; Baez L; Hong W K
Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(1):83-5.
-
1995: Mitchell M F; Hittelman W N; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Hong W K
Chemoprevention trials in the cervix: design, feasibility, and recruitment.
Journal of cellular biochemistry. Supplement 1995;23():104-12.
-
1995: Oridate N; Lotan D; Mitchell M F; Hong W K; Lotan R
Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention.
Journal of cellular biochemistry. Supplement 1995;23():80-6.
-
1995: Hong W K; Lippman S M
Cancer chemoprevention.
Journal of the National Cancer Institute. Monographs 1995;(17):49-53.
-
1995: Lippman S M; Heyman R A; Kurie J M; Benner S E; Hong W K
Retinoids and chemoprevention: clinical and basic studies.
Journal of cellular biochemistry. Supplement 1995;22():1-10.
-
1995: Lippman S M; Clayman G L; Huber M H; Benner S E; Hong W K
Biology and reversal of aerodigestive tract carcinogenesis.
Cancer treatment and research 1995;74():89-115.
-
1995: Clayman G L; Chamberlain R M; Lee J J; Lippman S M; Hong W K
Screening at a health fair to identify subjects for an oral leukoplakia chemoprevention trial.
Journal of cancer education : the official journal of the American Association for Cancer Education 1995;10(2):88-90.
-
1994: Benner S E; Pajak T F; Stetz J; Lippman S M; Hong W K; Schantz S P; Gallagher M J; Shenouda G
Toxicity of isotretinoin in a chemoprevention trial to prevent second primary tumors following head and neck cancer.
Journal of the National Cancer Institute 1994;86(23):1799-801.
-
1994: Shin D M; Hittelman W N; Hong W K
Biomarkers in upper aerodigestive tract tumorigenesis: a review.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(8):697-709.
-
1994: Spitz M R; Hoque A; Trizna Z; Schantz S P; Amos C I; King T M; Bondy M L; Hong W K; Hsu T C
Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract.
Journal of the National Cancer Institute 1994;86(22):1681-4.
-
1994: Benner S E; Lippman S M; Wargovich M J; Lee J J; Velasco M; Martin J W; Toth B B; Hong W K
Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy.
International journal of cancer. Journal international du cancer 1994;59(4):457-9.
-
1994: Lippman S M; Spitz M; Trizna Z; Benner S E; Hong W K
Epidemiology, biology, and chemoprevention of aerodigestive cancer.
Cancer 1994;74(9 Suppl):2719-25.
-
1994: Benner S E; Lippman S M; Hong W K
Retinoid lung cancer prevention.
Lung cancer (Amsterdam, Netherlands) 1994;11 Suppl 3():S71-8.
-
1994: Eisenhauer E A; Lippman S M; Kavanagh J J; Parades-Espinoza M; Arnold A; Hong W K; Massimini G; Schleuniger U; Bollag W; Holdener E E
Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(10):1622-5.
-
1994: Moore D M; Kalvakolanu D V; Lippman S M; Kavanagh J J; Hong W K; Borden E C; Paredes-Espinoza M; Krakoff I H
Retinoic acid and interferon in human cancer: mechanistic and clinical studies.
Seminars in hematology 1994;31(4 Suppl 5):31-7.
-
1994: Benner S E; Lippman S M; Hong W K
Retinoid chemoprevention of second primary tumors.
Seminars in hematology 1994;31(4 Suppl 5):26-30.
-
1994: Mitchell M F; Hittelman W N; Hong W K; Lotan R; Schottenfeld D
The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(7):619-26.
-
1994: Zou C P; Clifford J L; Xu X C; Sacks P G; Chambon P; Hong W K; Lotan R
Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines.
Cancer research 1994;54(20):5479-87.
-
1994: Xu X C; Ro J Y; Lee J S; Shin D M; Hong W K; Lotan R
Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues.
Cancer research 1994;54(13):3580-7.
-
1994: Huber M H; Lippman S M; Hong W K
Chemoprevention of head and neck cancer.
Seminars in oncology 1994;21(3):366-75.
-
1994: Shin D M; Ro J Y; Hong W K; Hittelman W N
Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.
Cancer research 1994;54(12):3153-9.
-
1994: Lippman S M; Donovan D T; Frankenthaler R A; Weber R S; Earley C L; Hong W K; Goepfert H
13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis.
Journal of the National Cancer Institute 1994;86(11):859-61.
-
1994: Shin D M; Ro J Y; Hong W K
Biomarkers in chemoprevention for upper aerodigestive tract tumors.
Yonsei medical journal 1994;35(2):113-31.
-
1994: Xu X C; Clifford J L; Hong W K; Lotan R
Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1994;3(2):122-31.
-
1994: Park H S; Shin D M; Lee J S; Komaki R; Pollack A; Putnam J B; Cox J D; Hong W K
Thymoma. A retrospective study of 87 cases.
Cancer 1994;73(10):2491-8.
-
1994: Lippman S M; Hong W K
13-cis-retinoic acid plus interferon-alpha in solid tumors: keeping the cart behind the horse.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(5):391-3.
-
1994: Lippman S M; Benner S E; Hong W K
Cancer chemoprevention.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):851-73.
-
1994: Perez-Soler R; Donato N J; Shin D M; Rosenblum M G; Zhang H Z; Tornos C; Brewer H; Chan J C; Lee J S; Hong W K
Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):730-9.
-
1994: Lippman S M; Benner S E; Hong W K
Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.
Cancer research 1994;54(7 Suppl):2025s-2028s.
-
1994: Huber M H; Hong W K
Biology and chemoprevention of head and neck cancer.
Current problems in cancer 1994;18(2):81-140.
-
1994: Benner S E; Pastorino U; Lippman S M; Hong W K
Second international cancer chemoprevention conference.
Cancer research 1994;54(3):854-6.
-
1994: Kurie J M; Lippman S M; Hong W K
Potential of retinoids in cancer prevention.
Cancer treatment reviews 1994;20(1):1-10.
-
1994: Lee J S; Hong W K
Timing of radiotherapy in small cell lung cancer.
International journal of radiation oncology, biology, physics 1994;28(2):543-5.
-
1994: Shin D M; Kim J; Ro J Y; Hittelman J; Roth J A; Hong W K; Hittelman W N
Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.
Cancer research 1994;54(2):321-6.
-
1994: Benner S E; Pajak T F; Lippman S M; Earley C; Hong W K
Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up.
Journal of the National Cancer Institute 1994;86(2):140-1.
-
1994: Benner S E; Wargovich M J; Lippman S M; Fisher R; Velasco M; Winn R J; Hong W K
Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(1):73-6.
-
1994: Benner S E; Lippman S M; Hong W K
Chemoprevention of second primary tumours: a model for intervention trials.
European journal of cancer (Oxford, England : 1990) 1994;30A(6):727-9.
-
1994: Shin D M; Holoye P Y; Forman A; Winn R; Perez-Soler R; Dakhil S; Rosenthal J; Raber M N; Hong W K
Phase II clinical trial of didemnin B in previously treated small cell lung cancer.
Investigational new drugs 1994;12(3):243-9.
-
1994: Huber M H; Shirinian M; Lippman S M; Dimery I W; Frankenthaler R A; Hong W K
Phase I/II study of cisplatin, 5-fluorouracil and alpha-interferon for recurrent carcinoma of the head and neck.
Investigational new drugs 1994;12(3):223-9.
-
1994: Eisenhauer E A; Lippman S M; Kavanagh J J; Parades-Espinoza M; Arnold A; Hong W K; Massimini G; Schleuniger U; Bollag W; Holdener E E
Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8 Suppl 3():S38-41.
-
1994: Hong W K; Benner S E; Lippman S M
Evolution of aerodigestive tract 13-cis-retinoid acid chemoprevention: the M.D. Anderson experience.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8 Suppl 3():S33-7.
-
1994: Huber M H; Dimery I W; Benner S E; Lippman S M; Shirinian M; Esparaz B; Frenning D; Guillory-Perez C; Hong W K
Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck.
Investigational new drugs 1994;12(4):327-31.
-
1993: Lee J S; Kim S Y; Hong W K; Lippman S M; Ro J Y; Gay M L; Hittelman W N
Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion.
Journal of the National Cancer Institute 1993;85(23):1951-4.
-
1993: Hong W K; Lippman S M; Wolf G T
Recent advances in head and neck cancer--larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture.
Cancer research 1993;53(21):5113-20.
-
1993: Dimery I W; Peters L J; Goepfert H; Morrison W H; Byers R M; Guillory C; McCarthy K; Weber R S; Hong W K
Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1919-28.
-
1993: Benner S E; Hong W K
Clinical chemoprevention: developing a cancer prevention strategy.
Journal of the National Cancer Institute 1993;85(18):1446-7.
-
1993: Lippman S M; Benner S E; Hong W K
Retinoids in chemoprevention of head and neck carcinogenesis.
Preventive medicine 1993;22(5):693-700.
-
1993: Lippman S M; Benner S E; Hong W K
Chemoprevention. Strategies for the control of cancer.
Cancer 1993;72(3 Suppl):984-90.
-
1993: Toth B B; Martin J W; Lippman S M; Hong W K
Chemoprevention as a form of cancer control.
Journal of the American Dental Association (1939) 1993;124(7):243-6.
-
1993: Lippman S M; Hong W K
Not yet standard: retinoids versus second primary tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1204-7.
-
1993: Voravud N; Shin D M; Ro J Y; Lee J S; Hong W K; Hittelman W N
Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis.
Cancer research 1993;53(12):2874-83.
-
1993: Shin D M; Voravud N; Ro J Y; Lee J S; Hong W K; Hittelman W N
Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
Journal of the National Cancer Institute 1993;85(12):971-8.
-
1993: Lee J S; Newman R A; Lippman S M; Huber M H; Minor T; Raber M N; Krakoff I H; Hong W K
Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(5):959-66.
-
1993: Peters E J; Morice R; Benner S E; Lippman S; Lukeman J; Lee J S; Ro J Y; Hong W K
Squamous metaplasia of the bronchial mucosa and its relationship to smoking.
Chest 1993;103(5):1429-32.
-
1993: Huber M H; Lee J S; Hong W K
Chemoprevention of lung cancer.
Seminars in oncology 1993;20(2):128-41.
-
1993: Chung K Y; Mukhopadhyay T; Kim J; Casson A; Ro J Y; Goepfert H; Hong W K; Roth J A
Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Cancer research 1993;53(7):1676-83.
-
1993: Lippman S M; Kavanagh J J; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong W K; Massimini G; Holdener E E; Krakoff I H
13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.
Journal of the National Cancer Institute 1993;85(6):499-500.
-
1993: Trizna Z; Benner S E; Shirley L; Furlong C; Hong W K
N-(4-hydroxyphenyl) retinamide is anticlastogenic in human lymphoblastoid cell lines.
Anticancer research 1993;13(2):355-6.
-
1993: Rinaldi D A; Lippman S M; Burris H A; Chou C; Von Hoff D D; Hong W K
Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer.
Anti-cancer drugs 1993;4(1):33-6.
-
1993: Huber M H; Hong W K
Warfarin and small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):383.
-
1993: Voravud N; Lippman S M; Weber R S; Rodriquez G I; Yee D; Dimery I W; Earley C L; Von Hoff D D; Hong W K
Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer.
Investigational new drugs 1993;11(1):57-60.
-
1993: Shin D M; Chiao P J; Sacks P G; Shin H J; Hong W K; Hittelman W N; Tainsky M A
Activation of ribosomal protein S2 gene expression in a hamster model of chemically induced oral carcinogenesis.
Carcinogenesis 1993;14(1):163-6.
-
1993: Dimery I W; Hong W K
Overview of combined modality therapies for head and neck cancer.
Journal of the National Cancer Institute 1993;85(2):95-111.
-
1993: Vokes E E; Weichselbaum R R; Lippman S M; Hong W K
Head and neck cancer.
The New England journal of medicine 1993;328(3):184-94.
-
1993: Lippman S M; Benner S E; Hong W K
Chemoprevention strategies in lung carcinogenesis.
Chest 1993;103(1 Suppl):15S-19S.
-
1993: Lippman S M; Batsakis J G; Toth B B; Weber R S; Lee J J; Martin J W; Hays G L; Goepfert H; Hong W K
Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.
The New England journal of medicine 1993;328(1):15-20.
-
1993: Benner S E; Winn R J; Lippman S M; Poland J; Hansen K S; Luna M A; Hong W K
Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study.
Journal of the National Cancer Institute 1993;85(1):44-7.
-
1993: Kim S Y; Lee J S; Ro J Y; Gay M L; Hong W K; Hittelman W N
Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Mapping genotype/phenotype heterogeneity.
The American journal of pathology 1993;142(1):307-17.
-
1993: Benner S E; Wargovich M J; Lippman S M; Hong W K
Micronuclei: a potential intermediate marker for chemoprevention of aerodigestive tract cancer.
Journal of cellular biochemistry. Supplement 1993;17F():250-4.
-
1993: Hittelman W N; Voravud N; Shin D M; Lee J S; Ro J Y; Hong W K
Early genetic changes during upper aerodigestive tract tumorigenesis.
Journal of cellular biochemistry. Supplement 1993;17F():233-6.
-
1993: Lippman S M; Glisson B S; Kavanagh J J; Lotan R; Hong W K; Paredes-Espinoza M; Hittelman W N; Holdener E E; Krakoff I H
Retinoic acid and interferon combination studies in human cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A Suppl 5():S9-13.
-
1993: Trizna Z; Schantz S P; Lee J J; Spitz M R; Goepfert H; Hsu T C; Hong W K
In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients.
Cancer detection and prevention 1993;17(6):575-83.
-
1992: Shirinian M; Lee J S; Dhingra H H; Greenberg J; Hong W K
Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report.
Seminars in oncology 1992;19(6 Suppl 12):58-63.
-
1992: Fossella F V; Winn R J; Holoye P Y; Hallinan B; Raber M N; Hoelzer K; Young J A; Readling J; Bowers B; Hong W K
Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinoma.
Investigational new drugs 1992;10(4):331-5.
-
1992: Heyne K H; Lippman S M; Lee J J; Lee J S; Hong W K
The incidence of second primary tumors in long-term survivors of small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1519-24.
-
1992: Benner S E; Lippman S M; Wargovich M J; Velasco M; Peters E J; Morice R C; Hong W K
Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis.
International journal of cancer. Journal international du cancer 1992;52(1):44-7.
-
1992: Benner S E; Lippman S M; Hong W K
Current status of chemoprevention of head and neck cancer.
Oncology (Williston Park, N.Y.) 1992;6(8):61-6; discussion 66-8, 71 passim.
-
1992: Voravud N; Shin D M; Dekmezian R H; Dimery I; Lee J S; Hong W K
Implantation metastasis of carcinoma after percutaneous fine-needle aspiration biopsy.
Chest 1992;102(1):313-5.
-
1992: Lee J S; Libshitz H I; Fossella F V; Murphy W K; Pang A C; Lippman S M; Shin D M; Dimery I W; Glisson B S; Hong W K
Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.
Journal of the National Cancer Institute 1992;84(13):1039-40.
-
1992: Lee J S; Hong W K
Prognostic factors in lung cancer.
The New England journal of medicine 1992;327(1):47-8.
-
1992: Shin D M; Dhingra H M; Lee J S; Fossella F V; Murphy W K; Hong W K
Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancer.
American journal of clinical oncology 1992;15(3):194-9.
-
1992: Benner S E; Lippman S M; Hong W K
Chemoprevention strategies for lung and upper aerodigestive tract cancer.
Cancer research 1992;52(9 Suppl):2758s-2763s.
-
1992: Lee J S; Lippman S M; Hong W K; Ro J Y; Kim S Y; Lotan R; Hittelman W N
Determination of biomarkers for intermediate end points in chemoprevention trials.
Cancer research 1992;52(9 Suppl):2707s-2710s.
-
1992: Shin H J; Lee J S; Hong W K; Shin D M
Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.
Anticancer research 1992;12(2):367-70.
-
1992: Lippman S M; Kavanagh J J; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong W K; Holdener E; Krakoff I H
13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
Journal of the National Cancer Institute 1992;84(4):241-5.
-
1992: Lippman S M; Parkinson D R; Itri L M; Weber R S; Schantz S P; Ota D M; Schusterman M A; Krakoff I H; Gutterman J U; Hong W K
13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
Journal of the National Cancer Institute 1992;84(4):235-41.
-
1992: Shirinian M; Lee J S; Dhingra H H; Greenberg J; Hong W K
Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
Seminars in oncology 1992;19(1 Suppl 1):49-53.
-
1992: Hong W K
Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on Intergroup Study 0034.
International journal of radiation oncology, biology, physics 1992;23(4):885-6.
-
1992: Chiao P J; Shin D M; Sacks P G; Hong W K; Tainsky M A
Elevated expression of the ribosomal protein S2 gene in human tumors.
Molecular carcinogenesis 1992;5(3):219-31.
-
1992: Benner S E; Hong W K; Lippman S M; Lee J S; Hittelman W M
Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials.
Journal of cellular biochemistry. Supplement 1992;16G():33-8.
-
1992: Lippman S M; Hong W K
Chemoprevention of aerodigestive epithelial cancers.
Advances in experimental medicine and biology 1992;320():151-61.
-
1992: Lippman S M; Hong W K
13-cis-retinoic acid and cancer chemoprevention.
Journal of the National Cancer Institute. Monographs 1992;(13):111-5.
-
1992: Kim J S; Steck P A; Gallick G E; Lee J S; Blick M; Hong W K; Lotan R
Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells.
Journal of the National Cancer Institute. Monographs 1992;(13):101-10.
-
1992: Lippman S M; Hong W K
Retinoid chemoprevention of upper aerodigestive tract carcinogenesis.
Important advances in oncology 1992;():93-109.
-
1992: Trizna Z; Hsu T C; Schantz S P; Lee J J; Hong W K
Anticlastogenic effects of 13-cis-retinoic acid in vitro.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):137-40.
-
1991: Dimery I W; Brooks B J; Winn R; Martin T; Shirinian M; Hong W K
Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(11):1939-44.
-
1991: Zatopek N K; Holoye P Y; Ellerbroek N A; Hong W K; Roth J A; Ryan M B; Komaki R; Pang A C; Glisson B S
Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).
American journal of clinical oncology 1991;14(5):427-32.
-
1991: Lee J S; Libshitz H I; Fossella F V; Murphy W K; Pang A C; Lippman S M; Shin D M; Dimery I W; Glisson B S; Hong W K
Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.
Cancer 1991;68(5):959-64.
-
1991: Heyne K E; Lippman S M; Hong W K
Chemoprevention in head and neck cancer.
Hematology/oncology clinics of North America 1991;5(4):783-95.
-
1991: Lippman S M; Hong W K
Beta-carotene didn't prevent cancer: what's up doc?
Journal of the National Cancer Institute 1991;83(15):1110-1.
-
1991: Karp D D; Vaughan C W; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong M S; Hong W K
Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
American journal of clinical oncology 1991;14(4):273-9.
-
1991: Yang S C; Grimm E A; Parkinson D R; Carinhas J; Fry K D; Mendiguren-Rodriguez A; Licciardello J; Owen-Schaub L B; Hong W K; Roth J A
Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.
Cancer research 1991;51(14):3669-76.
-
1991: Poddar S; Hong W K; Thacher S M; Lotan R
Retinoic acid suppression of squamous differentiation in human head-and-neck squamous carcinoma cells.
International journal of cancer. Journal international du cancer 1991;48(2):239-47.
-
1991: Lee J S; Ro J Y; Sahin A A; Hong W K; Brown B W; Mountain C F; Hittelman W N
Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer.
The New England journal of medicine 1991;324(16):1084-90.
-
1991: Shin D M; Kramer A M; Dimery I W; Raber M N; Ewer M; Hong W K
Phase II clinical trial of 4'-O-tetrahydropyranyl-adriamycin (THP-adriamycin) in recurrent squamous cell carcinoma of the head and neck.
Investigational new drugs 1991;9(1):89-91.
-
1991: Dhingra H M; Murphy W K; Winn R J; Raber M N; Hong W K
Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma.
Investigational new drugs 1991;9(1):69-72.
-
1991: Lippman S M; Hittelman W N; Lotan R; Pastorino U; Hong W K
Recent advances in cancer chemoprevention.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1991;3(2):59-65.
-
1991: Shin H J; Shin D M; Grant G; Hong W K; Pathak S
Simultaneous amplification of epidermal growth factor-receptor and multidrug-resistance genes in a newly. Established human lung cancer cell line.
Anticancer research 1991;11(1):241-8.
-
1991: Shin D M; Holoye P Y; Murphy W K; Forman A; Papasozomenos S C; Hong W K; Raber M
Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting.
Cancer chemotherapy and pharmacology 1991;29(2):145-9.
-
1991: Lee J S; Murphy W K; Shirinian M H; Pang A; Hong W K
Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy.
Cancer chemotherapy and pharmacology 1991;28(3):199-204.
-
1990: Hong W K; Lippman S M; Itri L M; Karp D D; Lee J S; Byers R M; Schantz S P; Kramer A M; Lotan R; Peters L J
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
The New England journal of medicine 1990;323(12):795-801.
-
1990: Shin D M; Fidler I J; Bucana C D; Fan D; Hong W K; Killion J J
Superior antiproliferative effects mediated by interferon-alpha entrapped in liposomes against a newly established human lung cancer cell line.
Journal of biological response modifiers 1990;9(4):355-60.
-
1990: Lee J S; Libshitz H I; Murphy W K; Jeffries D; Hong W K
Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancer.
Investigational new drugs 1990;8(3):299-304.
-
1990: Nicaise C; Hong W K; Dimery W; Usakewicz J; Rozencweig M; Krakoff I
Phase II study of tallysomycin S10b in patients with advanced head and neck cancer.
Investigational new drugs 1990;8(3):325-8.
-
1990: Gimenez-Conti I B; Shin D M; Bianchi A B; Roop D R; Hong W K; Conti C J; Slaga T J
Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
Cancer research 1990;50(14):4441-5.
-
1990: Dimery I W; Legha S S; Shirinian M; Hong W K
Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(6):1056-62.
-
1990: Lippman S M; Peters E J; Wargovich M J; Stadnyk A N; Dixon D O; Dekmezian R H; Loewy J W; Morice R C; Cunningham J E; Hong W K
Bronchial micronuclei as a marker of an early stage of carcinogenesis in the human tracheobronchial epithelium.
International journal of cancer. Journal international du cancer 1990;45(5):811-5.
-
1990: Lippman S M; Lee J S; Lotan R; Hittelman W; Wargovich M J; Hong W K
Biomarkers as intermediate end points in chemoprevention trials.
Journal of the National Cancer Institute 1990;82(7):555-60.
-
1990: Holoye P Y; Glisson B S; Lee J S; Dhingra H M; Murphy W K; Umsawasdi T; Levy J K; Jeffries D; Raber M N; Hong W K
Ifosfamide with mesna uroprotection in the management of lung cancer.
American journal of clinical oncology 1990;13(2):148-55.
-
1990: Shin D M; Gimenez I B; Lee J S; Nishioka K; Wargovich M J; Thacher S; Lotan R; Slaga T J; Hong W K
Expression of epidermal growth factor receptor, polyamine levels, ornithine decarboxylase activity, micronuclei, and transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model.
Cancer research 1990;50(8):2505-10.
-
1990: Sahin A A; Ro J Y; el-Naggar A K; Lee J S; Ayala A G; Teague K; Hong W K
Flow cytometric analysis of the DNA content of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung.
Cancer 1990;65(3):530-7.
-
1990: Lippman S M; Lee J S; Lotan R; Hong W K
Chemoprevention of upper aerodigestive tract cancers: a report of the third Upper Aerodigestive Cancer Task Force workshop.
Head & neck 1990;12(1):5-20.
-
1990: Yang S C; Owen-Schaub L; Mendiguren-Rodriguez A; Grimm E A; Hong W K; Roth J A
Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha.
The Journal of thoracic and cardiovascular surgery 1990;99(1):8-12; discussion 12-3.
-
1990: Jetten A M; Kim J S; Sacks P G; Rearick J I; Lotan D; Hong W K; Lotan R
Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid.
International journal of cancer. Journal international du cancer 1990;45(1):195-202.
-
1990: Dimery I W; Wendt C D; Kramer A M; Byers R M; Hong W K
The role of induction chemotherapy for organ preservation in laryngeal carcinoma.
Cancer treatment and research 1990;52():209-22.
-
1990: Lippman S M; Peters E J; Wargovich M J; Dixon D O; Dekmezian R H; Cunningham J E; Loewy J W; Morice R C; Hong W K
The evaluation of micronuclei as an intermediate endpoint of bronchial carcinogenesis.
Progress in clinical and biological research 1990;339():165-77.
-
1989: Lippman S M; Hong W K
Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease.
International journal of radiation oncology, biology, physics 1989;17(3):691-4.
-
1989: Licciardello J T; Spitz M R; Hong W K
Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung.
International journal of radiation oncology, biology, physics 1989;17(3):467-76.
-
1989: Lee J S; Murphy W K; Glisson B S; Dhingra H M; Holoye P Y; Hong W K
Primary chemotherapy of brain metastasis in small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(7):916-22.
-
1989: Schantz S P; Savage H E; Racz T; Liu F J; Brown B W; Rossen R D; Hong W K
Immunologic determinants of head and neck cancer response to induction chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(7):857-64.
-
1989: Dimery I W; Jacobs C; Tseng A; Saks S; Pearson G; Hong W K; Gutterman J U
Recombinant interferon-gamma in the treatment of recurrent nasopharyngeal carcinoma.
Journal of biological response modifiers 1989;8(3):221-6.
-
1989: Hong W K; Nicaise C; Lawson R; Maroun J A; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(4):450-6.
-
1989: Dimery I W; Kramer A M; Choksi A J; Hong W K
Neoadjuvant chemotherapy and radiotherapy in larynx preservation.
American journal of clinical oncology 1989;12(2):173-7.
-
1989: Kim H K; Zwelling L A; Sacks P G; Hong W K; Chan D; Silberman L; Glisson B S
Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line.
Cancer research 1989;49(5):1197-201.
-
1989: Chawla S P; Benjamin R S; Ayala A G; Carrasco C H; Hong W K; Martin R G
Advanced basal cell carcinoma and successful treatment with chemotherapy.
Journal of surgical oncology 1989;40(1):68-72.
-
1989: Hersh E M; Murray J L; Hong W K; Rosenblum M G; Reuben J M; Weilbaecher R; Sarwal A N; Bradley E C; Konrad M; Arnett F C
Phase I study of cancer therapy with recombinant interleukin-2 administered by intravenous bolus injection.
Biotherapy (Dordrecht, Netherlands) 1989;1(3):215-26.
-
1988: Stadnyk A N; Choksi A J; Hong W K
Retinoids and cancer prevention.
Texas medicine 1988;84(11):56-9.
-
1988: Schantz S P; Savage H E; Brown B W; Reuben J M; Hong W K; Rossen R D
Association of levels of circulating C1q binding macromolecules with induction chemotherapy response in head and neck cancer patients.
Cancer research 1988;48(20):5868-73.
-
1988: Shin D M; Ince C; Shtalrid M; Lee J S; Ro J S; Donner L; Ferrell R E; Hong W K; Wildrick D; Blick M
Reduction to homozygosity at the SIS/PDGF-2 locus in human mesenchymal tumors.
Biochemical and biophysical research communications 1988;155(2):692-9.
-
1988: Bell R; Hong W K; Itri L M; McDonald G; Strong M S
The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a randomized pilot study.
American journal of otolaryngology 1988;9(4):161-4.
-
1988: Choksi A J; Dimery I W; Hong W K
Adjuvant chemotherapy of head and neck cancer: the past, the present, and the future.
Seminars in oncology 1988;15(3 Suppl 3):45-59.
-
1988: Toth B B; Weber R S; Hong W K
Oral cancer: a preventable disease?
Texas dental journal 1988;105(6):8-11.
-
1988: Paredes J; Hong W K; Felder T B; Dimery I W; Choksi A J; Newman R A; Castellanos A M; Robbins K T; McCarthy K; Atkinson N
Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(6):955-62.
-
1988: Dimery I W; Lee J S; Blick M; Pearson G; Spitzer G; Hong W K
Association of the Epstein-Barr virus with lymphoepithelioma of the thymus.
Cancer 1988;61(12):2475-80.
-
1988: Ishihara J; Saijo N; Kanzawa F; Matsushima Y; Sasaki Y; Takahashi H; Nakano H; Nakagawa K; Hong W S; Hoshi A
Augmentation of colony formation of cultured cell lines by pleural effusion from patients with lung cancer.
European journal of cancer & clinical oncology 1988;24(3):497-8.
-
1988: Choksi A J; Hong W K; Dimery I W; James P; Guillamondegui O M; Byers R M
Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinoma.
Cancer 1988;61(5):909-12.
-
1988: Spitz M R; Fueger J J; Goepfert H; Hong W K; Newell G R
Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis.
Cancer 1988;61(1):203-8.
-
1988: Hong W K
Induction chemotherapy for advanced head and neck cancer.
Head & neck surgery 1988;10(3):147-9.
-
1988: Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Sakurai M; Suga J; Nakano H; Nakagawa K; Hong W S
Cytogenetic effect of carboplatin on human lymphocytes.
Cancer chemotherapy and pharmacology 1988;21(3):203-7.
-
1987: Dimery I W; Nishioka K; Grossie V B; Ota D M; Schantz S P; Byers R; Robbins K T; Hong W K
Polyamine metabolism in carcinoma of the oral cavity compared with adjacent and normal oral mucosa.
American journal of surgery 1987;154(4):429-33.
-
1987: Dimery I W; Jones L A; Verjan R P; Raymond A K; Goepfert H; Hong W K
Estrogen receptors in normal salivary gland and salivary gland carcinoma.
Archives of otolaryngology--head & neck surgery 1987;113(10):1082-5.
-
1987: Goepfert H; Barker J L; Close L G; el-Domeiri A H; Epley D E; Helfrick J F; Hong W K; Lehane D E; Neal G D; O'Brien J C
Head and neck cancer. Head and Neck Oncology Workgroup, Legislative Task Force on Cancer in Texas.
Texas medicine 1987;83(9 Pt 2):4-16.
-
1987: Lotan R; Sacks P G; Lotan D; Hong W K
Differential effects of retinoic acid on the in vitro growth and cell-surface glycoconjugates of 2 human head and neck squamous-cell carcinomas.
International journal of cancer. Journal international du cancer 1987;40(2):224-9.
-
1987: Hong W K
Multiple primary squamous cell carcinoma of the head and neck.
American journal of clinical oncology 1987;10(2):182-3.
-
1987: Dimery I W; Neidhart J A; McCarthy K; Krakoff I H; Hong W K
Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck.
Cancer treatment reports 1987;71(4):425-6.
-
1986: Hong W K; Endicott J; Itri L M; Doos W; Batsakis J G; Bell R; Fofonoff S; Byers R; Atkinson E N; Vaughan C
13-cis-retinoic acid in the treatment of oral leukoplakia.
The New England journal of medicine 1986;315(24):1501-5.
-
1986: Friedman H M; Sheetz S; Levine H L; Everett J R; Hong W K
Combination chemotherapy and radiation therapy. The medical management of epidural spinal cord compression from testicular cancer.
Archives of internal medicine 1986;146(3):509-12.
-
1986: Cersosimo R J; Hong W K
Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(3):425-39.
-
1986: O'Donoghue G M; Hong W K
Chemotherapy in cancer of the head and neck.
Irish medical journal 1986;79(1):20-3.
-
1985: Licciardello J T; Cersosimo R J; Karp D D; Hoffer S M; Paquette-Tello D A; Hong W K
Disturbing central nervous system complications following combination chemotherapy and prophylactic whole-brain irradiation in patients with small cell lung cancer.
Cancer treatment reports 1985;69(12):1429-30.
-
1985: Hong W K; Bromer R H; Amato D A; Shapshay S; Vincent M; Vaughan C; Willett B; Katz A; Welch J; Fofonoff S
Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy.
Cancer 1985;56(6):1242-5.
-
1985: Hong W K; Doos W G
Chemoprevention of head and neck cancer. Potential use of retinoids.
Otolaryngologic clinics of North America 1985;18(3):543-9.
-
1985: Kies M S; Levitan N; Hong W K
Chemotherapy of head and neck cancer.
Otolaryngologic clinics of North America 1985;18(3):533-41.
-
1985: Levitan N; Byrne R E; Bromer R H; Faling L J; Caslowitz P; Pattern D H; Hong W K
The value of the bone scan and bone marrow biopsy staging small cell lung cancer.
Cancer 1985;56(3):652-4.
-
1985: Popkin J D; Hong W K; Cersosimo R J; Faling L J; Snow M N; Fofonoff S A
A prospective randomized trial of combination vindesine and cisplatin versus single-agent vindesine in advanced non-small cell lung cancer.
Pharmacotherapy 1985;5(1):20-2.
-
1985: Hong W K; O'Donoghue G M; Sheetz S; Fofonoff S; Dorman E B; Welch J; Vaughan C W; Karp D D; Willett B; Strong S
Sequential response patterns to chemotherapy and radiotherapy in head and neck cancer: potential impact of treatment in advanced laryngeal cancer.
Progress in clinical and biological research 1985;201():191-7.
-
1985: Seder R H; Katz A E; Keggins J J; Blanchard G C; Oh S K; Berman L D; Vaughan C W; Hong W K; Strong M S
Plasma exchange in six patients with advanced cancers of the head and neck.
Journal of clinical apheresis 1985;2(3):238-49.
-
1985: Licciardello J T; Moake J L; Rudy C K; Karp D D; Hong W K
Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy.
Oncology 1985;42(5):296-300.
-
1984: Dorman E B; Yang H; Vaughan C W; Hong W K; Strong M S
The incidence of hypercalcemia in squamous cell carcinoma of the head and neck.
Head & neck surgery 1984;7(2):95-8.
-
1984: Levitan N; Hong W K; Byrne R E; Gale M E; Bromer R H; Levine H L; Licciardello J T; Abbruzzese J L
Role of computerized cranial tomography in the staging of small cell carcinoma of the lung.
Cancer treatment reports 1984;68(11):1375-7.
-
1984: Cersosimo R J; Licciardello J T; Matthews S J; Bromer R; Hong W K
Acute pneumonitis associated with MOPP chemotherapy of Hodgkin's disease.
Drug intelligence & clinical pharmacy 1984;18(7-8):609-11.
-
1984: Popkin J D; Hong W K; Bromer R H; Hoffer S M; Doos W G; Willett B L; Katz A E; Vaughan C W; Strong M S
Induction bleomycin infusion in head and neck cancer.
American journal of clinical oncology 1984;7(3):199-204.
-
1983: Cersosimo R J; Bromer R; Licciardello J T; Hong W K
Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid.
Pharmacotherapy 1983;3(5):259-74.
-
1983: Hong W K; Schaefer S; Issell B; Cummings C; Luedke D; Bromer R; Fofonoff S; D'Aoust J; Shapshay S; Welch J; Levin E; Vincent M; Vaughan C; Strong S
A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck.
Cancer 1983;52(2):206-10.
-
1983: Popkin J D; Bromer R H; Vaughan C W; Byrne R E; Licciardello J T; Hoffer S M; Welch J M; Fofonoff S A; Strong M S; Hong W K
Continuous vindesine infusion in advanced head and neck cancer.
American journal of clinical oncology 1983;6(3):301-4.
-
1983: Hong W K; Bromer R
Chemotherapy in head and neck cancer.
The New England journal of medicine 1983;308(2):75-9.
-
1982: Pennacchio J L; Hong W K; Shapshay S; Gillis T; Vaughan C; Bhutani P; Ucmakli A; Katz A E; Bromer R; Willet B; Strong S M
Combination of cis-platinum and bleomycin prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced squamous cell carcinoma of the head and neck.
Cancer 1982;50(12):2795-801.
-
1982: Gillis T M; Shapshay S M; Hong W K; Pennachio J; Simpson G T; Strong M S
A comparison of combined modalities and single modality in the management of advanced head and neck tumors.
The Laryngoscope 1982;92(9 Pt 1):993-8.
-
1981: Hong W K; Bhutani R; Gerzof S G; Doos W G
Chemotherapy for primary retroperitoneal yolk sac tumor: report of a case.
Cancer 1981;47(1):19-21.
-
1980: Shapshay S M; Hong W K; Incze J S; Sismanis A; Bhutani R; Vaughn C W; Strong M S
Prognostic indicators in induction cis-platinum bleomycin chemotherapy for advanced head and neck cancer.
American journal of surgery 1980;140(4):543-8.
-
1980: Shapshay S M; Hong W K; Fried M P; Sismanis A; Vaughan C W; Strong M S
Simultaneous carcinomas of the esophagus and upper aerodigestive tract.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1980;88(4):373-7.
-
1980: Katz A E; Hong W K; Bhutani R; Berman L D; Blanchard G J; Koff R S; Shapshay S M; Strong M S
Prognostic indicators in chemotherapy for head and neck carcinoma: alkaline phosphatase levels.
The Laryngoscope 1980;90(6 Pt 1):924-9.
-
1980: Hong W K; Shapshay S M
Treatment of previously untreated stage III and IV squamous cell carcinoma of the head and neck.
Otolaryngologic clinics of North America 1980;13(3):521-8.
-
1979: Hong W K; Shapshay S M; Bhutani R; Craft M L; Ucmakli A; Yamaguchi K T; Vaughan C W; Strong M S
Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion.
Cancer 1979;44(1):19-25.
-
1978: Spechler S J; Esposito A L; Koff R S; Hong W K
Lactic acidosis in oat cell carcinoma with extensive hepatic metastases.
Archives of internal medicine 1978;138(11):1663-4.
-
1978: Shapshay S M; Hong W K; Incze J S; Yamaguchi K; Bhutani R; Vaughan C W; Strong M S
Histopathologic findings after cis-platinum bleomycin therapy in advanced previously untreated head and neck carcinoma.
American journal of surgery 1978;136(4):534-8.
-
1978: Green G J; Hong W K; Everett J R; Bhutani R; Amick R M
Familial intraocular malignant melanoma: a case report.
Cancer 1978;41(6):2481-3.
-
1977: Hong W K; Wittes R E; Hajdu S T; Cvitkovic E; Whitmore W F; Golbey R B
The evolution of mature teratoma from malignant testicular tumors.
Cancer 1977;40(6):2987-92.
Sign-in to see more